PKCH
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A2RRP1 | S473 | Sugiyama | NBAS NAG | APKRSRLETRAGEEDEGEEDsDsDyEISAKARYFGYIKQGL |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A6NMY6 | S26 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| O00571 | S82 | Sugiyama | DDX3X DBX DDX3 | ssKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRs |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O75821 | T240 | Sugiyama | EIF3G EIF3S4 | DGAsRRGESMQPNRRADDNAtIRVtNLSEDTRETDLQELFR |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S27 | SIGNOR | ANXA1 ANX1 LPC1 | FLKQAWFIENEEQEyVQtVKssKGGPGsAVsPyPtFNPssD |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P05107 | S745 | SIGNOR|ELM|PSP | ITGB2 CD18 MFI7 | ALIHLSDLREyRRFEKEKLKsQWNNDNPLFKsAtttVMNPK |
| P05107 | T758 | SIGNOR|ELM|PSP | ITGB2 CD18 MFI7 | FEKEKLKsQWNNDNPLFKsAtttVMNPKFAES_________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07355 | S26 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09211 | S185 | SIGNOR|PSP | GSTP1 FAEES3 GST3 | VLAPGCLDAFPLLSAYVGRLsARPKLKAFLASPEyVNLPIN |
| P09211 | S43 | SIGNOR|PSP | GSTP1 FAEES3 GST3 | ADQGQSWKEEVVTVETWQEGsLKASCLyGQLPKFQDGDLtL |
| P09234 | S19 | Sugiyama | SNRPC | __MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKENVKDYYQ |
| P09651 | S360 | Sugiyama | HNRNPA1 HNRPA1 | PyGGGGQyFAKPRNQGGyGGssssssyGsGRRF________ |
| P09651 | S368 | Sugiyama | HNRNPA1 HNRPA1 | FAKPRNQGGyGGssssssyGsGRRF________________ |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09651 | Y357 | Sugiyama | HNRNPA1 HNRPA1 | ssGPyGGGGQyFAKPRNQGGyGGssssssyGsGRRF_____ |
| P09923 | S111 | Sugiyama | ALPI | DRFPYLALSKTYNVDRQVPDsAATATAYLCGVKANFQTIGL |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P15104 | S322 | Sugiyama | GLUL GLNS | GFHETSNINDFSAGVANRsAsIRIPRTVGQEKKGYFEDRRP |
| P18615 | S131 | Sugiyama | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P24723 | S28 | PSP | PRKCH PKCL PRKCL | FNGYLRVRIGEAVGLQPtRWsLRHsLFKKGHQLLDPYLTVS |
| P24723 | S317 | Sugiyama | PRKCH PKCL PRKCL | VNAVELAKTLAGMGLQPGNIsPtsKLVSRSTLRRQGKESSK |
| P24723 | S32 | PSP | PRKCH PKCL PRKCL | LRVRIGEAVGLQPtRWsLRHsLFKKGHQLLDPYLTVSVDQV |
| P24723 | S599 | Sugiyama | PRKCH PKCL PRKCL | EDATGILKSFMTKNPTMRLGsLtQGGEHAILRHPFFKEIDW |
| P24723 | T177 | Sugiyama | PRKCH PKCL PRKCL | KRQRAMRRRVHQINGHKFMAtyLRQPtYCSHCREFIWGVFG |
| P24723 | T183 | Sugiyama | PRKCH PKCL PRKCL | RRRVHQINGHKFMAtyLRQPtYCSHCREFIWGVFGKQGYQC |
| P24723 | T207 | Sugiyama | PRKCH PKCL PRKCL | HCREFIWGVFGKQGYQCQVCtCVVHKRCHHLIVTACTCQNN |
| P24723 | T601 | Sugiyama | PRKCH PKCL PRKCL | ATGILKSFMTKNPTMRLGsLtQGGEHAILRHPFFKEIDWAQ |
| P24723 | Y178 | Sugiyama | PRKCH PKCL PRKCL | RQRAMRRRVHQINGHKFMAtyLRQPtYCSHCREFIWGVFGK |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25789 | T9 | Sugiyama | PSMA4 HC9 PSC9 | ____________MSRRyDsRttIFsPEGRLYQVEYAMEAIG |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29474 | T495 | SIGNOR | NOS3 | YQPDPWKGSAAKGTGITRKKtFKEVANAVKISASLMGTVMA |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P35236 | S246 | SIGNOR | PTPN7 | KECPEYTVRQLTIQYQEERRsVKHILFSAWPDHQTPESAGP |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46060 | S24 | Sugiyama | RANGAP1 KIAA1835 SD | EDIAKLAETLAKTQVAGGQLsFKGKSLKLNTAEDAKDVIKE |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P49840 | S21 | SIGNOR|PSP | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | S9 | SIGNOR|PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P52789 | S415 | Sugiyama | HK2 | QRIKENKGEERLRstIGVDGsVyKKHPHFAKRLHKTVRRLV |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P55196 | S216 | Sugiyama | AFDN AF6 MLLT4 | SRLAAEVYKDMPETSFTRtIsNPEVVMKRRRQQKLEKRMQE |
| P56270 | S302 | Sugiyama | MAZ ZNF801 | EMCGKAFRDVYHLNRHKLSHsDEKPyQCPVCQQRFKRKDRM |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P78417 | S23 | Sugiyama | GSTO1 GSTTLP28 | GESARsLGKGsAPPGPVPEGsIRIySMRFCPFAERTRLVLK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02156 | T175 | Sugiyama | PRKCE PKCE | KRQGAVRRRVHQVNGHKFMAtyLRQPtYCSHCRDFIWGVIG |
| Q02156 | T181 | Sugiyama | PRKCE PKCE | RRRVHQVNGHKFMAtyLRQPtYCSHCRDFIWGVIGKQGYQC |
| Q02156 | T205 | Sugiyama | PRKCE PKCE | HCRDFIWGVIGKQGYQCQVCtCVVHKRCHELIITKCAGLKK |
| Q02156 | Y176 | Sugiyama | PRKCE PKCE | RQGAVRRRVHQVNGHKFMAtyLRQPtYCSHCRDFIWGVIGK |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q06124 | S576 | SIGNOR|PSP | PTPN11 PTP2C SHPTP2 | DQSPLPPCTPTPPCAEMREDsARVyENVGLMQQQKsFR___ |
| Q06124 | S591 | PSP | PTPN11 PTP2C SHPTP2 | EMREDsARVyENVGLMQQQKsFR__________________ |
| Q14004 | S389 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | SYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVLRRSGKS |
| Q14103 | S271 | Sugiyama | HNRNPD AUF1 HNRPD | KCEIKVAMSKEQyQQQQQWGsRGGFAGRARGRGGGPSQNWN |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15139 | S738 | SIGNOR|ELM|iPTMNet|PSP | PRKD1 PKD PKD1 PRKCM | DPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNK |
| Q15139 | S742 | SIGNOR|ELM|PSP | PRKD1 PKD PKD1 PRKCM | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNR |
| Q16629 | S183 | Sugiyama | SRSF7 SFRS7 | sRSISLRRSRSASLRRSRSGsIKGsRyFQsPsRsRsRSRSI |
| Q16629 | S187 | Sugiyama | SRSF7 SFRS7 | SLRRSRSASLRRSRSGsIKGsRyFQsPsRsRsRSRSISRPR |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZL6 | S706 | SIGNOR|PSP | PRKD2 PKD2 HSPC187 | DPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLLNQ |
| Q9BZL6 | S710 | SIGNOR|PSP | PRKD2 PKD2 HSPC187 | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLLNQGyNR |
| Q9BZL6 | S876 | SIGNOR|PSP | PRKD2 PKD2 HSPC187 | DLGGACPPQDHDMQGLAERIsVL__________________ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NYF8 | S297 | Sugiyama | BCLAF1 BTF KIAA0164 | VGNGssRysPsQNsPIHHIPsRRsPAKtIAPQNAPRDEsRG |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9ULX6 | T267 | Sugiyama | AKAP8L NAKAP NAKAP95 HRIHFB2018 | RFGFGFGNGMKQMRRTWKTWtTADFRTKKKKRKQGGsPDEP |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 7.771561e-16 | 15.109 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.796963e-14 | 13.421 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.321165e-12 | 11.879 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.417200e-12 | 11.849 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.371703e-12 | 11.270 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.951099e-10 | 9.530 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.014818e-10 | 9.396 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.238404e-10 | 9.084 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.155219e-09 | 8.667 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.333855e-09 | 8.477 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.624820e-09 | 8.179 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.446173e-09 | 8.073 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.549598e-08 | 7.594 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.701906e-08 | 7.568 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.428319e-08 | 7.354 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.859467e-08 | 7.232 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.244711e-08 | 7.204 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.884280e-08 | 7.162 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.029435e-08 | 7.153 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.307591e-08 | 7.136 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.719462e-08 | 7.112 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.088684e-07 | 6.963 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.219064e-07 | 6.914 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.331259e-07 | 6.876 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.331259e-07 | 6.876 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.427862e-07 | 6.845 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.694265e-07 | 6.771 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.703298e-07 | 6.769 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.858564e-07 | 6.731 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.216041e-07 | 6.654 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.381413e-07 | 6.623 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.938335e-07 | 6.532 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.906581e-07 | 6.537 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.996735e-07 | 6.398 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.563606e-07 | 6.341 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.955429e-07 | 6.305 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.261124e-07 | 6.279 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.460221e-07 | 6.190 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.460221e-07 | 6.190 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.643132e-07 | 6.063 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.286319e-07 | 6.032 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.601908e-07 | 6.018 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.228796e-06 | 5.911 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.319839e-06 | 5.879 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.357521e-06 | 5.867 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.746448e-06 | 5.758 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.761544e-06 | 5.754 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.921537e-06 | 5.716 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.187691e-06 | 5.660 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.474662e-06 | 5.606 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.489938e-06 | 5.604 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.680892e-06 | 5.572 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.779038e-06 | 5.556 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.881426e-06 | 5.540 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.835190e-06 | 5.547 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.147153e-06 | 5.502 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.298750e-06 | 5.482 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.474076e-06 | 5.459 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.738916e-06 | 5.427 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.977835e-06 | 5.400 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.307621e-06 | 5.366 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.307621e-06 | 5.366 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.331768e-06 | 5.363 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.587494e-06 | 5.338 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.587494e-06 | 5.338 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.803988e-06 | 5.318 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.602392e-06 | 5.252 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.038407e-06 | 5.219 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.821973e-06 | 5.166 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.266244e-06 | 5.083 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.593356e-06 | 5.018 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.700533e-06 | 5.013 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.073689e-05 | 4.969 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.104589e-05 | 4.957 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.862659e-05 | 4.730 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.868412e-05 | 4.729 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.868412e-05 | 4.729 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.075357e-05 | 4.683 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.844399e-05 | 4.546 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.909009e-05 | 4.536 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.004586e-05 | 4.522 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.341015e-05 | 4.362 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.694328e-05 | 4.328 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.962689e-05 | 4.304 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.749318e-05 | 4.171 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.117116e-05 | 4.148 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.140006e-05 | 4.146 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.529697e-05 | 4.123 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.596398e-05 | 4.119 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.960722e-05 | 4.099 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.512183e-05 | 4.070 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.568019e-05 | 4.067 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.624008e-05 | 4.064 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.093252e-05 | 4.041 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.132133e-04 | 3.946 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.166169e-04 | 3.933 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.175074e-04 | 3.930 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.270395e-04 | 3.896 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.339715e-04 | 3.873 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.351064e-04 | 3.869 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.360373e-04 | 3.866 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.371488e-04 | 3.863 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.522477e-04 | 3.817 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.716950e-04 | 3.765 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.736121e-04 | 3.760 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.913989e-04 | 3.718 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.809232e-04 | 3.743 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.097839e-04 | 3.678 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.155958e-04 | 3.666 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.155958e-04 | 3.666 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.365222e-04 | 3.626 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.892521e-04 | 3.539 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.540862e-04 | 3.451 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.557575e-04 | 3.449 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.801911e-04 | 3.420 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.183527e-04 | 3.378 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.987551e-04 | 3.399 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.987551e-04 | 3.399 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.987551e-04 | 3.399 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.987551e-04 | 3.399 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.247957e-04 | 3.372 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.577040e-04 | 3.339 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.577040e-04 | 3.339 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.310348e-04 | 3.275 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.773874e-04 | 3.239 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.827415e-04 | 3.235 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.099249e-04 | 3.215 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.249376e-04 | 3.204 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.887611e-04 | 3.162 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.182989e-04 | 3.144 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.623571e-04 | 3.118 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.792847e-04 | 3.108 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.806030e-04 | 3.108 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.010808e-04 | 3.096 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.277791e-04 | 3.082 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.289612e-04 | 3.032 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.586473e-04 | 3.066 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.578435e-04 | 3.067 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.904981e-04 | 3.050 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.081529e-04 | 3.042 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.314137e-04 | 3.031 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.425161e-04 | 3.026 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.425161e-04 | 3.026 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.094995e-03 | 2.961 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.153121e-03 | 2.938 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.183900e-03 | 2.927 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.200850e-03 | 2.921 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.201659e-03 | 2.920 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.256165e-03 | 2.901 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.273839e-03 | 2.895 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.360244e-03 | 2.866 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.432688e-03 | 2.844 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.458079e-03 | 2.836 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.432688e-03 | 2.844 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.557215e-03 | 2.808 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.578251e-03 | 2.802 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.605459e-03 | 2.794 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.638312e-03 | 2.786 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.726519e-03 | 2.763 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.747973e-03 | 2.757 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.833574e-03 | 2.737 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.846587e-03 | 2.734 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.869420e-03 | 2.728 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.934343e-03 | 2.713 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.941518e-03 | 2.712 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.106755e-03 | 2.676 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.956731e-03 | 2.708 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.112976e-03 | 2.675 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.088089e-03 | 2.680 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.286552e-03 | 2.641 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.372147e-03 | 2.625 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.396294e-03 | 2.620 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.463248e-03 | 2.608 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.534432e-03 | 2.596 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.874263e-03 | 2.541 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.898430e-03 | 2.538 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.911770e-03 | 2.536 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.963802e-03 | 2.528 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.974036e-03 | 2.527 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.322055e-03 | 2.479 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.374459e-03 | 2.472 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.393271e-03 | 2.469 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.543999e-03 | 2.451 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.588857e-03 | 2.445 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.932049e-03 | 2.405 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.079665e-03 | 2.389 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.038091e-03 | 2.394 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.164300e-03 | 2.380 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.164300e-03 | 2.380 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.226046e-03 | 2.374 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.674312e-03 | 2.330 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.676865e-03 | 2.330 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.676865e-03 | 2.330 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.685199e-03 | 2.329 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.844397e-03 | 2.315 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.844397e-03 | 2.315 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.274023e-03 | 2.278 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.538408e-03 | 2.257 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.346048e-03 | 2.197 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.367563e-03 | 2.196 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.492608e-03 | 2.188 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.889435e-03 | 2.162 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.910098e-03 | 2.161 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.018797e-03 | 2.154 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.144141e-03 | 2.089 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.115941e-03 | 2.091 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.771368e-03 | 2.110 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.579560e-03 | 2.120 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.255081e-03 | 2.139 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.158332e-03 | 2.088 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.184503e-03 | 2.087 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.294782e-03 | 2.081 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.294782e-03 | 2.081 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.867150e-03 | 2.052 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 9.045084e-03 | 2.044 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.186488e-03 | 2.037 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.488422e-03 | 2.023 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.813621e-03 | 2.008 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 9.912219e-03 | 2.004 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.935879e-03 | 2.003 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.014503e-02 | 1.994 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.033186e-02 | 1.986 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.108758e-02 | 1.955 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.111331e-02 | 1.954 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.143804e-02 | 1.942 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.143804e-02 | 1.942 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.143804e-02 | 1.942 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.178479e-02 | 1.929 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.191902e-02 | 1.924 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.191902e-02 | 1.924 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.191902e-02 | 1.924 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.196445e-02 | 1.922 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.196445e-02 | 1.922 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.411924e-02 | 1.850 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.411924e-02 | 1.850 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.290811e-02 | 1.889 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.332191e-02 | 1.875 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.429671e-02 | 1.845 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.481330e-02 | 1.829 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.507359e-02 | 1.822 | 1 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.618580e-02 | 1.791 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.621114e-02 | 1.790 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.635649e-02 | 1.786 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.635649e-02 | 1.786 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.653446e-02 | 1.782 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.722482e-02 | 1.764 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.722482e-02 | 1.764 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.725436e-02 | 1.763 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.782705e-02 | 1.749 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.821999e-02 | 1.739 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.872604e-02 | 1.728 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.872604e-02 | 1.728 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.883968e-02 | 1.725 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.897673e-02 | 1.722 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.927871e-02 | 1.715 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.038366e-02 | 1.691 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.092828e-02 | 1.679 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.104403e-02 | 1.677 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.111201e-02 | 1.675 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.128944e-02 | 1.672 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.211751e-02 | 1.655 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.225322e-02 | 1.653 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.401782e-02 | 1.619 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.251763e-02 | 1.647 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.328254e-02 | 1.633 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.613427e-02 | 1.583 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.568109e-02 | 1.590 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.328254e-02 | 1.633 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.560700e-02 | 1.592 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.474610e-02 | 1.606 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.673002e-02 | 1.573 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.675899e-02 | 1.573 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.675899e-02 | 1.573 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.710770e-02 | 1.567 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.722862e-02 | 1.565 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.791989e-02 | 1.554 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.875766e-02 | 1.541 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.897787e-02 | 1.538 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.900997e-02 | 1.537 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.900997e-02 | 1.537 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.900997e-02 | 1.537 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.917259e-02 | 1.535 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.917259e-02 | 1.535 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.917259e-02 | 1.535 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.917259e-02 | 1.535 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.917259e-02 | 1.535 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.931750e-02 | 1.533 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.010303e-02 | 1.521 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.079141e-02 | 1.512 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.143276e-02 | 1.503 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.171534e-02 | 1.499 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.182199e-02 | 1.497 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.382062e-02 | 1.471 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 3.382062e-02 | 1.471 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.382062e-02 | 1.471 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.382062e-02 | 1.471 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.382062e-02 | 1.471 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.382062e-02 | 1.471 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.382062e-02 | 1.471 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.382062e-02 | 1.471 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.398182e-02 | 1.469 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.718664e-02 | 1.430 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.718664e-02 | 1.430 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.685481e-02 | 1.434 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.612981e-02 | 1.442 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.679112e-02 | 1.434 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.516000e-02 | 1.454 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.516000e-02 | 1.454 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.731416e-02 | 1.428 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.534167e-02 | 1.452 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.830787e-02 | 1.417 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.830787e-02 | 1.417 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.685481e-02 | 1.434 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.122158e-02 | 1.385 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.065174e-02 | 1.391 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.737224e-02 | 1.427 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.682453e-02 | 1.434 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.685481e-02 | 1.434 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.487366e-02 | 1.458 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.130300e-02 | 1.384 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.130300e-02 | 1.384 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.166751e-02 | 1.380 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.246681e-02 | 1.372 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.246681e-02 | 1.372 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.327816e-02 | 1.364 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.327816e-02 | 1.364 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.354161e-02 | 1.361 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.354777e-02 | 1.361 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.512804e-02 | 1.346 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.601956e-02 | 1.337 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.601956e-02 | 1.337 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.691219e-02 | 1.329 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.691219e-02 | 1.329 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.697163e-02 | 1.328 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.798240e-02 | 1.319 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.864112e-02 | 1.313 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.897004e-02 | 1.310 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.202517e-02 | 1.284 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.261936e-02 | 1.279 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.261936e-02 | 1.279 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.261936e-02 | 1.279 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.261936e-02 | 1.279 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.261936e-02 | 1.279 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.357336e-02 | 1.271 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.496267e-02 | 1.260 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.539654e-02 | 1.257 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.539654e-02 | 1.257 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.938763e-02 | 1.159 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 6.938763e-02 | 1.159 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 6.938763e-02 | 1.159 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 6.938763e-02 | 1.159 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 6.938763e-02 | 1.159 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 6.938763e-02 | 1.159 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.938763e-02 | 1.159 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.598693e-02 | 1.252 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.598693e-02 | 1.252 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.598693e-02 | 1.252 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.598693e-02 | 1.252 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.598693e-02 | 1.252 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.698444e-02 | 1.244 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.642686e-02 | 1.178 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.642686e-02 | 1.178 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.783174e-02 | 1.238 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.783174e-02 | 1.238 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.796164e-02 | 1.168 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.741631e-02 | 1.241 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.550011e-02 | 1.184 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.612967e-02 | 1.251 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.344348e-02 | 1.198 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.741631e-02 | 1.241 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.796164e-02 | 1.168 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.676661e-02 | 1.246 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.741631e-02 | 1.241 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.598693e-02 | 1.252 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.162595e-02 | 1.210 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.986168e-02 | 1.223 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.550011e-02 | 1.184 | 1 | 1 |
| Pyroptosis | R-HSA-5620971 | 5.904003e-02 | 1.229 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.274876e-02 | 1.202 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.728047e-02 | 1.242 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.783174e-02 | 1.238 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.655517e-02 | 1.177 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.738745e-02 | 1.171 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.698444e-02 | 1.244 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.642686e-02 | 1.178 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.642686e-02 | 1.178 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.582817e-02 | 1.182 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.612967e-02 | 1.251 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.550011e-02 | 1.184 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.828415e-02 | 1.234 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.274876e-02 | 1.202 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.014907e-02 | 1.154 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.014907e-02 | 1.154 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.071013e-02 | 1.151 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.085466e-02 | 1.150 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.116825e-02 | 1.148 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.222882e-02 | 1.141 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.416461e-02 | 1.130 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.427786e-02 | 1.129 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.427786e-02 | 1.129 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.427786e-02 | 1.129 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.491184e-02 | 1.125 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.491184e-02 | 1.125 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.491184e-02 | 1.125 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.521537e-02 | 1.124 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.542150e-02 | 1.123 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.768361e-02 | 1.110 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.840532e-02 | 1.106 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.928953e-02 | 1.101 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 8.030710e-02 | 1.095 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 8.030710e-02 | 1.095 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 8.030710e-02 | 1.095 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 8.071133e-02 | 1.093 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.071133e-02 | 1.093 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.071133e-02 | 1.093 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.098673e-02 | 1.092 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.098673e-02 | 1.092 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.180366e-02 | 1.087 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.205662e-02 | 1.086 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.244308e-02 | 1.084 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.271213e-02 | 1.082 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.313410e-02 | 1.080 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.126144e-01 | 0.948 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.126144e-01 | 0.948 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.126144e-01 | 0.948 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.126144e-01 | 0.948 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.126144e-01 | 0.948 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.126144e-01 | 0.948 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.126144e-01 | 0.948 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.126144e-01 | 0.948 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.126144e-01 | 0.948 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.126144e-01 | 0.948 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.126144e-01 | 0.948 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.126144e-01 | 0.948 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.126144e-01 | 0.948 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.126144e-01 | 0.948 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.126144e-01 | 0.948 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.126144e-01 | 0.948 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.083781e-01 | 0.965 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.532995e-02 | 1.021 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 9.532995e-02 | 1.021 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.532995e-02 | 1.021 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.532995e-02 | 1.021 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 9.945672e-02 | 1.002 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 9.945672e-02 | 1.002 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 9.945672e-02 | 1.002 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.105961e-01 | 0.956 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.821063e-02 | 1.054 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.051714e-01 | 0.978 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.051714e-01 | 0.978 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.116669e-01 | 0.952 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.116669e-01 | 0.952 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.048246e-01 | 0.980 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.217799e-02 | 1.035 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.217799e-02 | 1.035 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.217799e-02 | 1.035 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.217799e-02 | 1.035 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.223821e-02 | 1.035 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.465261e-02 | 1.024 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.016857e-01 | 0.993 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.051714e-01 | 0.978 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.116669e-01 | 0.952 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 9.532995e-02 | 1.021 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.001879e-01 | 0.999 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.954105e-02 | 1.002 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.083781e-01 | 0.965 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.116669e-01 | 0.952 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.393989e-02 | 1.027 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.532995e-02 | 1.021 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.217799e-02 | 1.035 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.087698e-01 | 0.963 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.945672e-02 | 1.002 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.954105e-02 | 1.002 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.393989e-02 | 1.027 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.153053e-01 | 0.938 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.153053e-01 | 0.938 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.153053e-01 | 0.938 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.153053e-01 | 0.938 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.153053e-01 | 0.938 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.116901e-01 | 0.952 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 9.532995e-02 | 1.021 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.217799e-02 | 1.035 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.831968e-02 | 1.007 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.008849e-01 | 0.996 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.105961e-01 | 0.956 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.854867e-02 | 1.053 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.624518e-02 | 1.017 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.116901e-01 | 0.952 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.001997e-01 | 0.999 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.153053e-01 | 0.938 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.901327e-02 | 1.051 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.217799e-02 | 1.035 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.492377e-02 | 1.023 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 9.894634e-02 | 1.005 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.992636e-02 | 1.046 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.006441e-01 | 0.997 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.153623e-01 | 0.938 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.153623e-01 | 0.938 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.153623e-01 | 0.938 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.153623e-01 | 0.938 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.175012e-01 | 0.930 | 1 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.178004e-01 | 0.929 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.180620e-01 | 0.928 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.180620e-01 | 0.928 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.180620e-01 | 0.928 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.180620e-01 | 0.928 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.185448e-01 | 0.926 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.186381e-01 | 0.926 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.187790e-01 | 0.925 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.198367e-01 | 0.921 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.239613e-01 | 0.907 | 1 | 1 |
| PLC beta mediated events | R-HSA-112043 | 1.250446e-01 | 0.903 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.258087e-01 | 0.900 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.258847e-01 | 0.900 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.260120e-01 | 0.900 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.286668e-01 | 0.891 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.312733e-01 | 0.882 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.312733e-01 | 0.882 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.315107e-01 | 0.881 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.330511e-01 | 0.876 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.330511e-01 | 0.876 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.330511e-01 | 0.876 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.330511e-01 | 0.876 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.331567e-01 | 0.876 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.331567e-01 | 0.876 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.331567e-01 | 0.876 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.331567e-01 | 0.876 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.331567e-01 | 0.876 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.331567e-01 | 0.876 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.331567e-01 | 0.876 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.331567e-01 | 0.876 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.331567e-01 | 0.876 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.331567e-01 | 0.876 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.331567e-01 | 0.876 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.331567e-01 | 0.876 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.331567e-01 | 0.876 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.331567e-01 | 0.876 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.331567e-01 | 0.876 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.331567e-01 | 0.876 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.331567e-01 | 0.876 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.331567e-01 | 0.876 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.331567e-01 | 0.876 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.331567e-01 | 0.876 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.331567e-01 | 0.876 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.332741e-01 | 0.875 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.332741e-01 | 0.875 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.352401e-01 | 0.869 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.354353e-01 | 0.868 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.392127e-01 | 0.856 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.392127e-01 | 0.856 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.392127e-01 | 0.856 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.608323e-01 | 0.794 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.608323e-01 | 0.794 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.608323e-01 | 0.794 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 1.608323e-01 | 0.794 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.396378e-01 | 0.855 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.734919e-01 | 0.761 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.734919e-01 | 0.761 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.734919e-01 | 0.761 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.734919e-01 | 0.761 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.734919e-01 | 0.761 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.734919e-01 | 0.761 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.093475e-01 | 0.679 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.093475e-01 | 0.679 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.093475e-01 | 0.679 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.093475e-01 | 0.679 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.695564e-01 | 0.771 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.695564e-01 | 0.771 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.695564e-01 | 0.771 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.695564e-01 | 0.771 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.613306e-01 | 0.792 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.613306e-01 | 0.792 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.977980e-01 | 0.704 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.977980e-01 | 0.704 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.977980e-01 | 0.704 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.519394e-01 | 0.818 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.519394e-01 | 0.818 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.519394e-01 | 0.818 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.519394e-01 | 0.818 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.847523e-01 | 0.733 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.847523e-01 | 0.733 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.847523e-01 | 0.733 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.847523e-01 | 0.733 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.847523e-01 | 0.733 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.719411e-01 | 0.765 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 1.719411e-01 | 0.765 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.093195e-01 | 0.679 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.486240e-01 | 0.828 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.486240e-01 | 0.828 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.929594e-01 | 0.715 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.929594e-01 | 0.715 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 1.929594e-01 | 0.715 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.835336e-01 | 0.736 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.693713e-01 | 0.771 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.458842e-01 | 0.836 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.458842e-01 | 0.836 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.699860e-01 | 0.770 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.984125e-01 | 0.702 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.984125e-01 | 0.702 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.450675e-01 | 0.838 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.478275e-01 | 0.830 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.511284e-01 | 0.821 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.407973e-01 | 0.851 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.993734e-01 | 0.700 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.995176e-01 | 0.700 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.519394e-01 | 0.818 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.993734e-01 | 0.700 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.667810e-01 | 0.778 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.977980e-01 | 0.704 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.827478e-01 | 0.738 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.598566e-01 | 0.796 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.526467e-01 | 0.816 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.819495e-01 | 0.740 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.781709e-01 | 0.749 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.519394e-01 | 0.818 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.693713e-01 | 0.771 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.984125e-01 | 0.702 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.734919e-01 | 0.761 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.093195e-01 | 0.679 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.993734e-01 | 0.700 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.927321e-01 | 0.715 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.613306e-01 | 0.792 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.437788e-01 | 0.842 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.526467e-01 | 0.816 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.847523e-01 | 0.733 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.093475e-01 | 0.679 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.977980e-01 | 0.704 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.495174e-01 | 0.825 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.003757e-01 | 0.698 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.608323e-01 | 0.794 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.093195e-01 | 0.679 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.404490e-01 | 0.852 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.835336e-01 | 0.736 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.424498e-01 | 0.846 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.810100e-01 | 0.742 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 1.396378e-01 | 0.855 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.977980e-01 | 0.704 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.993734e-01 | 0.700 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.428877e-01 | 0.845 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.695564e-01 | 0.771 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.551729e-01 | 0.809 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.841635e-01 | 0.735 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.734919e-01 | 0.761 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.093475e-01 | 0.679 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.054422e-01 | 0.687 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.082659e-01 | 0.681 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.977980e-01 | 0.704 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.672364e-01 | 0.777 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.054422e-01 | 0.687 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.831741e-01 | 0.737 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.093475e-01 | 0.679 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.551729e-01 | 0.809 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.927046e-01 | 0.715 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.119468e-01 | 0.674 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.119468e-01 | 0.674 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.119468e-01 | 0.674 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.119468e-01 | 0.674 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.119468e-01 | 0.674 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.119468e-01 | 0.674 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.119468e-01 | 0.674 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.119468e-01 | 0.674 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.119468e-01 | 0.674 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.148889e-01 | 0.668 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.153988e-01 | 0.667 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.153988e-01 | 0.667 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.153988e-01 | 0.667 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.176851e-01 | 0.662 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.176851e-01 | 0.662 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.176851e-01 | 0.662 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.184870e-01 | 0.661 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.220189e-01 | 0.654 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.273334e-01 | 0.643 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.273334e-01 | 0.643 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.273334e-01 | 0.643 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.273334e-01 | 0.643 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.317692e-01 | 0.635 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.317692e-01 | 0.635 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.317757e-01 | 0.635 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.344635e-01 | 0.630 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.344635e-01 | 0.630 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.348656e-01 | 0.629 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.365971e-01 | 0.626 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.365971e-01 | 0.626 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.378391e-01 | 0.624 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.378712e-01 | 0.624 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.388834e-01 | 0.622 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.485894e-01 | 0.605 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.485894e-01 | 0.605 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.485894e-01 | 0.605 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.485894e-01 | 0.605 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.485894e-01 | 0.605 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.485894e-01 | 0.605 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.485894e-01 | 0.605 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.486563e-01 | 0.458 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.486563e-01 | 0.458 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.486563e-01 | 0.458 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.486563e-01 | 0.458 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.486563e-01 | 0.458 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.486563e-01 | 0.458 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.486563e-01 | 0.458 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.486563e-01 | 0.458 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.486563e-01 | 0.458 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.486563e-01 | 0.458 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.486563e-01 | 0.458 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.486563e-01 | 0.458 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.486563e-01 | 0.458 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.486563e-01 | 0.458 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.486563e-01 | 0.458 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.486563e-01 | 0.458 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 3.486563e-01 | 0.458 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.486563e-01 | 0.458 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.486563e-01 | 0.458 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.486563e-01 | 0.458 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.486563e-01 | 0.458 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.486563e-01 | 0.458 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.486563e-01 | 0.458 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.486563e-01 | 0.458 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.486563e-01 | 0.458 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.643325e-01 | 0.578 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.643325e-01 | 0.578 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.643325e-01 | 0.578 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.643325e-01 | 0.578 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.466371e-01 | 0.608 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.466371e-01 | 0.608 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.466371e-01 | 0.608 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.167452e-01 | 0.499 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.167452e-01 | 0.499 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.167452e-01 | 0.499 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.167452e-01 | 0.499 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.167452e-01 | 0.499 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.167452e-01 | 0.499 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.167452e-01 | 0.499 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 4.354021e-01 | 0.361 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.354021e-01 | 0.361 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.354021e-01 | 0.361 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.354021e-01 | 0.361 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.354021e-01 | 0.361 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 4.354021e-01 | 0.361 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.354021e-01 | 0.361 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.354021e-01 | 0.361 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.354021e-01 | 0.361 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.848332e-01 | 0.545 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.848332e-01 | 0.545 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.848332e-01 | 0.545 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.578825e-01 | 0.589 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.682492e-01 | 0.434 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.682492e-01 | 0.434 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.682492e-01 | 0.434 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.682492e-01 | 0.434 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.234581e-01 | 0.490 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.234581e-01 | 0.490 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.234581e-01 | 0.490 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.891715e-01 | 0.539 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.891715e-01 | 0.539 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.891715e-01 | 0.539 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.610318e-01 | 0.583 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.610318e-01 | 0.583 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.882126e-01 | 0.540 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.620887e-01 | 0.441 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.620887e-01 | 0.441 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.181574e-01 | 0.379 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.181574e-01 | 0.379 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.181574e-01 | 0.379 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.181574e-01 | 0.379 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.181574e-01 | 0.379 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.181574e-01 | 0.379 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.181574e-01 | 0.379 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.850117e-01 | 0.545 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.156741e-01 | 0.501 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.807486e-01 | 0.552 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.807486e-01 | 0.552 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.003580e-01 | 0.398 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.003580e-01 | 0.398 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.028848e-01 | 0.519 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.658159e-01 | 0.575 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.849349e-01 | 0.415 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.659816e-01 | 0.332 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.659816e-01 | 0.332 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.659816e-01 | 0.332 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.591748e-01 | 0.445 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.379537e-01 | 0.359 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.167297e-01 | 0.380 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.992751e-01 | 0.399 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.886563e-01 | 0.540 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.379058e-01 | 0.471 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.093412e-01 | 0.388 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.093412e-01 | 0.388 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.270570e-01 | 0.370 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.270570e-01 | 0.370 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.746165e-01 | 0.324 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.746165e-01 | 0.324 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.545766e-01 | 0.342 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.545766e-01 | 0.342 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.789833e-01 | 0.320 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.789833e-01 | 0.320 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.817191e-01 | 0.317 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.476259e-01 | 0.349 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.578961e-01 | 0.589 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.850768e-01 | 0.314 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.659558e-01 | 0.332 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.842574e-01 | 0.415 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.093412e-01 | 0.388 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.430536e-01 | 0.465 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.430536e-01 | 0.465 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.362512e-01 | 0.473 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.836720e-01 | 0.547 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.552134e-01 | 0.342 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.167297e-01 | 0.380 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.891715e-01 | 0.539 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.089381e-01 | 0.510 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.379537e-01 | 0.359 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.167297e-01 | 0.380 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.986994e-01 | 0.525 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.209380e-01 | 0.494 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.240381e-01 | 0.489 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.620887e-01 | 0.441 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.529351e-01 | 0.452 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.453253e-01 | 0.351 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.015455e-01 | 0.396 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 2.897738e-01 | 0.538 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.111478e-01 | 0.507 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.632670e-01 | 0.440 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.848332e-01 | 0.545 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.620887e-01 | 0.441 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.529351e-01 | 0.452 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.481337e-01 | 0.349 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.789833e-01 | 0.320 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.591204e-01 | 0.338 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.379537e-01 | 0.359 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.469751e-01 | 0.350 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.530144e-01 | 0.452 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.722192e-01 | 0.326 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.466371e-01 | 0.608 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.659816e-01 | 0.332 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.167297e-01 | 0.380 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.722192e-01 | 0.326 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.167452e-01 | 0.499 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.181574e-01 | 0.379 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.094396e-01 | 0.509 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.589837e-01 | 0.445 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.709685e-01 | 0.431 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.234581e-01 | 0.490 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.028848e-01 | 0.519 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 2.897738e-01 | 0.538 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.481337e-01 | 0.349 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.434411e-01 | 0.464 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.684071e-01 | 0.329 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.094396e-01 | 0.509 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.341988e-01 | 0.476 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.466371e-01 | 0.608 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.682492e-01 | 0.434 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.003580e-01 | 0.398 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.659816e-01 | 0.332 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 2.712020e-01 | 0.567 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.992751e-01 | 0.399 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.456178e-01 | 0.610 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.481337e-01 | 0.349 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.097010e-01 | 0.509 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.636900e-01 | 0.439 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.704134e-01 | 0.328 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.564948e-01 | 0.448 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.939368e-01 | 0.405 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.958372e-01 | 0.402 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.994794e-01 | 0.524 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.762615e-01 | 0.322 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.801641e-01 | 0.420 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.209380e-01 | 0.494 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.379537e-01 | 0.359 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.754715e-01 | 0.560 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.751626e-01 | 0.323 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.643325e-01 | 0.578 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.167452e-01 | 0.499 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.354021e-01 | 0.361 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.578825e-01 | 0.589 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.682492e-01 | 0.434 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.209380e-01 | 0.494 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.620887e-01 | 0.441 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 4.181574e-01 | 0.379 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.850117e-01 | 0.545 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.659816e-01 | 0.332 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.659816e-01 | 0.332 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.659816e-01 | 0.332 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.659816e-01 | 0.332 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.379537e-01 | 0.359 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.480265e-01 | 0.458 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.067342e-01 | 0.391 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.480812e-01 | 0.458 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.169061e-01 | 0.380 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.481337e-01 | 0.349 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.842574e-01 | 0.415 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.834063e-01 | 0.548 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.939368e-01 | 0.405 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.722192e-01 | 0.326 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.541070e-01 | 0.451 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.818102e-01 | 0.317 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.643325e-01 | 0.578 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.167452e-01 | 0.499 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.891715e-01 | 0.539 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.620887e-01 | 0.441 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.659816e-01 | 0.332 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.746165e-01 | 0.324 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.836366e-01 | 0.315 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.823960e-01 | 0.417 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.253581e-01 | 0.488 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.528756e-01 | 0.452 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.528756e-01 | 0.452 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.904967e-01 | 0.408 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 2.466371e-01 | 0.608 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.904967e-01 | 0.408 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.185032e-01 | 0.497 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.789833e-01 | 0.320 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.913556e-01 | 0.407 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.136938e-01 | 0.383 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.850117e-01 | 0.545 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.659816e-01 | 0.332 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.011590e-01 | 0.521 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.253581e-01 | 0.488 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.011590e-01 | 0.521 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.196547e-01 | 0.495 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.196547e-01 | 0.495 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.011590e-01 | 0.521 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.322658e-01 | 0.479 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.321069e-01 | 0.479 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.485894e-01 | 0.605 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.485894e-01 | 0.605 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.486563e-01 | 0.458 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.643325e-01 | 0.578 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.466371e-01 | 0.608 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.466371e-01 | 0.608 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 3.167452e-01 | 0.499 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.354021e-01 | 0.361 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.354021e-01 | 0.361 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.354021e-01 | 0.361 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.354021e-01 | 0.361 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.848332e-01 | 0.545 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.682492e-01 | 0.434 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.209380e-01 | 0.494 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.209380e-01 | 0.494 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.181574e-01 | 0.379 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.181574e-01 | 0.379 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.003580e-01 | 0.398 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.434411e-01 | 0.464 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.659816e-01 | 0.332 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.659816e-01 | 0.332 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.591748e-01 | 0.445 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.056604e-01 | 0.515 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.916447e-01 | 0.407 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.094396e-01 | 0.509 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.530568e-01 | 0.344 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.834063e-01 | 0.548 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.337114e-01 | 0.477 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.659816e-01 | 0.332 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.032588e-01 | 0.518 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.697856e-01 | 0.328 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.850117e-01 | 0.545 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.713573e-01 | 0.430 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.169061e-01 | 0.380 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 2.712020e-01 | 0.567 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.992751e-01 | 0.399 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.789833e-01 | 0.320 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.128867e-01 | 0.384 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.093412e-01 | 0.388 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.591748e-01 | 0.445 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.612203e-01 | 0.583 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.486571e-01 | 0.348 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.643325e-01 | 0.578 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.354021e-01 | 0.361 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.848332e-01 | 0.545 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.891715e-01 | 0.539 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.620887e-01 | 0.441 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.379537e-01 | 0.359 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.271092e-01 | 0.485 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.341988e-01 | 0.476 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.156741e-01 | 0.501 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.860381e-01 | 0.413 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.521201e-01 | 0.598 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.643325e-01 | 0.578 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.643325e-01 | 0.578 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.181574e-01 | 0.379 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.253581e-01 | 0.488 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.850768e-01 | 0.314 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.754100e-01 | 0.323 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.612203e-01 | 0.583 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.167452e-01 | 0.499 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.167452e-01 | 0.499 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.891715e-01 | 0.539 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.485890e-01 | 0.605 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.944627e-01 | 0.404 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.167297e-01 | 0.380 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.992751e-01 | 0.399 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.709685e-01 | 0.431 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.167297e-01 | 0.380 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.862104e-01 | 0.313 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.871334e-01 | 0.312 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.896295e-01 | 0.310 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.900725e-01 | 0.310 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.046272e-01 | 0.297 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.073296e-01 | 0.295 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.073296e-01 | 0.295 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.073296e-01 | 0.295 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.073296e-01 | 0.295 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.083816e-01 | 0.294 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 5.091367e-01 | 0.293 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.091367e-01 | 0.293 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.091367e-01 | 0.293 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.091367e-01 | 0.293 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.091367e-01 | 0.293 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.091367e-01 | 0.293 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.101360e-01 | 0.292 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.101360e-01 | 0.292 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.101360e-01 | 0.292 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.101360e-01 | 0.292 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.101360e-01 | 0.292 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.101360e-01 | 0.292 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.101360e-01 | 0.292 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.105995e-01 | 0.292 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.105995e-01 | 0.292 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.105995e-01 | 0.292 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.105995e-01 | 0.292 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 5.105995e-01 | 0.292 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.105995e-01 | 0.292 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.105995e-01 | 0.292 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.105995e-01 | 0.292 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.105995e-01 | 0.292 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 5.105995e-01 | 0.292 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.105995e-01 | 0.292 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.105995e-01 | 0.292 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.105995e-01 | 0.292 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.105995e-01 | 0.292 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.113917e-01 | 0.291 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 5.113917e-01 | 0.291 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.113917e-01 | 0.291 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.113917e-01 | 0.291 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.113917e-01 | 0.291 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.113917e-01 | 0.291 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.113917e-01 | 0.291 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.113917e-01 | 0.291 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.113917e-01 | 0.291 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.246191e-01 | 0.280 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.274123e-01 | 0.278 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.292466e-01 | 0.276 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.304303e-01 | 0.275 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.313256e-01 | 0.275 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.315287e-01 | 0.274 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.315287e-01 | 0.274 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.344735e-01 | 0.272 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.344735e-01 | 0.272 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 5.375338e-01 | 0.270 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.384736e-01 | 0.269 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.384736e-01 | 0.269 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.384736e-01 | 0.269 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.384736e-01 | 0.269 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.443466e-01 | 0.264 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.443466e-01 | 0.264 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.443466e-01 | 0.264 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.443466e-01 | 0.264 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.443466e-01 | 0.264 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.467723e-01 | 0.262 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.507754e-01 | 0.259 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.541826e-01 | 0.256 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.541826e-01 | 0.256 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.541826e-01 | 0.256 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.541826e-01 | 0.256 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.541826e-01 | 0.256 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.541826e-01 | 0.256 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.547698e-01 | 0.256 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.547698e-01 | 0.256 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.577037e-01 | 0.254 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.577037e-01 | 0.254 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.603868e-01 | 0.252 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.604330e-01 | 0.251 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.636044e-01 | 0.249 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.636044e-01 | 0.249 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.641242e-01 | 0.249 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.668941e-01 | 0.246 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.668941e-01 | 0.246 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.668941e-01 | 0.246 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.668941e-01 | 0.246 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.668941e-01 | 0.246 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.673509e-01 | 0.246 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.673509e-01 | 0.246 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.686888e-01 | 0.245 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.700119e-01 | 0.244 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.738567e-01 | 0.241 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.738567e-01 | 0.241 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.757853e-01 | 0.240 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 5.757853e-01 | 0.240 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.757853e-01 | 0.240 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 5.757853e-01 | 0.240 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.757853e-01 | 0.240 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 5.757853e-01 | 0.240 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.757853e-01 | 0.240 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.757853e-01 | 0.240 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.757853e-01 | 0.240 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.757853e-01 | 0.240 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.757853e-01 | 0.240 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.757853e-01 | 0.240 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.757853e-01 | 0.240 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.757853e-01 | 0.240 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.760244e-01 | 0.240 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.771231e-01 | 0.239 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.771231e-01 | 0.239 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.771231e-01 | 0.239 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.771231e-01 | 0.239 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.774636e-01 | 0.238 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.774636e-01 | 0.238 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.779272e-01 | 0.238 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.827631e-01 | 0.235 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.827631e-01 | 0.235 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.846410e-01 | 0.233 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.846410e-01 | 0.233 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.867481e-01 | 0.232 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.942463e-01 | 0.226 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.942463e-01 | 0.226 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.942463e-01 | 0.226 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.942463e-01 | 0.226 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.942463e-01 | 0.226 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.942463e-01 | 0.226 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.942463e-01 | 0.226 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 5.942463e-01 | 0.226 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.943175e-01 | 0.226 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.976519e-01 | 0.224 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.003114e-01 | 0.222 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.004263e-01 | 0.222 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.026363e-01 | 0.220 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.032079e-01 | 0.220 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.070648e-01 | 0.217 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.083760e-01 | 0.216 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.083760e-01 | 0.216 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.083760e-01 | 0.216 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.083760e-01 | 0.216 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.083760e-01 | 0.216 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.083760e-01 | 0.216 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.085932e-01 | 0.216 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.085932e-01 | 0.216 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.132723e-01 | 0.212 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.176125e-01 | 0.209 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.183298e-01 | 0.209 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.197364e-01 | 0.208 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.206808e-01 | 0.207 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.206808e-01 | 0.207 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.206808e-01 | 0.207 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.315503e-01 | 0.200 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.315503e-01 | 0.200 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.315503e-01 | 0.200 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.315503e-01 | 0.200 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.315503e-01 | 0.200 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.317266e-01 | 0.199 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.321433e-01 | 0.199 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.321433e-01 | 0.199 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.322919e-01 | 0.199 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.322919e-01 | 0.199 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.322919e-01 | 0.199 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.322919e-01 | 0.199 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.322919e-01 | 0.199 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.322919e-01 | 0.199 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.322919e-01 | 0.199 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.322919e-01 | 0.199 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.322919e-01 | 0.199 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.322919e-01 | 0.199 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.322919e-01 | 0.199 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.322919e-01 | 0.199 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.322919e-01 | 0.199 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.322919e-01 | 0.199 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.322919e-01 | 0.199 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.380469e-01 | 0.195 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.380469e-01 | 0.195 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.380469e-01 | 0.195 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.380469e-01 | 0.195 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.380469e-01 | 0.195 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.380469e-01 | 0.195 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.380469e-01 | 0.195 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.380469e-01 | 0.195 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.380469e-01 | 0.195 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.380469e-01 | 0.195 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.384493e-01 | 0.195 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.397607e-01 | 0.194 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.402794e-01 | 0.194 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.422721e-01 | 0.192 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.459375e-01 | 0.190 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.459375e-01 | 0.190 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.459375e-01 | 0.190 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.459375e-01 | 0.190 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.466968e-01 | 0.189 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.509623e-01 | 0.186 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.511272e-01 | 0.186 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.511272e-01 | 0.186 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.511272e-01 | 0.186 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.516128e-01 | 0.186 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.516128e-01 | 0.186 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.540056e-01 | 0.184 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.540056e-01 | 0.184 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.594281e-01 | 0.181 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.619014e-01 | 0.179 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.661045e-01 | 0.176 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.661045e-01 | 0.176 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.661045e-01 | 0.176 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.661188e-01 | 0.176 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.661188e-01 | 0.176 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.661188e-01 | 0.176 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.661188e-01 | 0.176 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.661188e-01 | 0.176 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.661188e-01 | 0.176 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 6.661188e-01 | 0.176 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.661188e-01 | 0.176 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.661188e-01 | 0.176 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.661188e-01 | 0.176 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.661188e-01 | 0.176 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.661188e-01 | 0.176 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.661188e-01 | 0.176 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.679510e-01 | 0.175 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.695167e-01 | 0.174 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.700560e-01 | 0.174 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.700560e-01 | 0.174 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.700560e-01 | 0.174 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.754036e-01 | 0.170 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.756323e-01 | 0.170 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.761392e-01 | 0.170 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.768243e-01 | 0.170 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.806927e-01 | 0.167 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.812745e-01 | 0.167 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.812745e-01 | 0.167 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.812745e-01 | 0.167 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.812745e-01 | 0.167 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.812745e-01 | 0.167 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.812745e-01 | 0.167 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.812745e-01 | 0.167 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.812745e-01 | 0.167 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.812745e-01 | 0.167 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.812745e-01 | 0.167 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.812745e-01 | 0.167 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.812745e-01 | 0.167 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.812745e-01 | 0.167 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.812745e-01 | 0.167 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.812745e-01 | 0.167 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.812745e-01 | 0.167 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.812745e-01 | 0.167 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 6.812745e-01 | 0.167 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 6.812745e-01 | 0.167 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.812745e-01 | 0.167 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.812745e-01 | 0.167 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.812745e-01 | 0.167 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.812745e-01 | 0.167 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.872941e-01 | 0.163 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.898311e-01 | 0.161 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.903335e-01 | 0.161 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.905411e-01 | 0.161 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.925402e-01 | 0.160 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.925402e-01 | 0.160 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.930176e-01 | 0.159 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.930176e-01 | 0.159 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.930176e-01 | 0.159 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.930176e-01 | 0.159 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.930176e-01 | 0.159 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.933078e-01 | 0.159 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.959027e-01 | 0.157 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.980186e-01 | 0.156 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.980186e-01 | 0.156 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.980186e-01 | 0.156 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.980186e-01 | 0.156 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.980186e-01 | 0.156 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 6.980186e-01 | 0.156 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.980186e-01 | 0.156 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.980186e-01 | 0.156 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.980186e-01 | 0.156 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.980186e-01 | 0.156 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.980186e-01 | 0.156 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.992306e-01 | 0.155 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.999031e-01 | 0.155 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.050231e-01 | 0.152 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.091265e-01 | 0.149 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.092469e-01 | 0.149 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.092469e-01 | 0.149 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.148158e-01 | 0.146 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.148158e-01 | 0.146 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.148158e-01 | 0.146 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.148158e-01 | 0.146 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.173645e-01 | 0.144 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.173645e-01 | 0.144 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.173645e-01 | 0.144 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.173645e-01 | 0.144 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.190705e-01 | 0.143 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.237346e-01 | 0.140 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.237346e-01 | 0.140 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.237346e-01 | 0.140 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 7.237346e-01 | 0.140 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.237346e-01 | 0.140 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.237346e-01 | 0.140 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 7.237346e-01 | 0.140 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.237346e-01 | 0.140 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.237346e-01 | 0.140 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 7.237346e-01 | 0.140 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.237346e-01 | 0.140 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.237346e-01 | 0.140 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.237346e-01 | 0.140 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.237346e-01 | 0.140 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.237346e-01 | 0.140 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.246337e-01 | 0.140 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.273472e-01 | 0.138 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.273472e-01 | 0.138 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.273472e-01 | 0.138 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.273472e-01 | 0.138 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.273472e-01 | 0.138 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.273472e-01 | 0.138 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 7.273472e-01 | 0.138 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.273472e-01 | 0.138 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.273472e-01 | 0.138 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.273472e-01 | 0.138 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.326772e-01 | 0.135 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.341700e-01 | 0.134 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.346539e-01 | 0.134 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.349230e-01 | 0.134 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.354538e-01 | 0.133 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.354538e-01 | 0.133 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.354538e-01 | 0.133 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.354538e-01 | 0.133 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.354538e-01 | 0.133 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.394628e-01 | 0.131 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.394764e-01 | 0.131 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.406038e-01 | 0.130 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.493254e-01 | 0.125 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.519379e-01 | 0.124 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.520781e-01 | 0.124 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.520781e-01 | 0.124 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.520781e-01 | 0.124 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.542233e-01 | 0.123 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.542233e-01 | 0.123 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.542233e-01 | 0.123 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.542233e-01 | 0.123 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.542233e-01 | 0.123 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.542233e-01 | 0.123 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.542233e-01 | 0.123 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.542233e-01 | 0.123 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.549442e-01 | 0.122 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.549442e-01 | 0.122 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.559550e-01 | 0.122 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.605403e-01 | 0.119 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.605403e-01 | 0.119 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.605403e-01 | 0.119 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.605403e-01 | 0.119 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.605403e-01 | 0.119 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.605403e-01 | 0.119 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.605403e-01 | 0.119 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.605403e-01 | 0.119 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.605403e-01 | 0.119 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.605403e-01 | 0.119 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.605403e-01 | 0.119 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.622972e-01 | 0.118 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.622972e-01 | 0.118 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.622972e-01 | 0.118 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.622972e-01 | 0.118 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.666730e-01 | 0.115 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.666730e-01 | 0.115 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.688047e-01 | 0.114 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.688047e-01 | 0.114 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.733067e-01 | 0.112 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.781805e-01 | 0.109 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.787799e-01 | 0.109 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.787799e-01 | 0.109 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.787799e-01 | 0.109 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.787799e-01 | 0.109 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.787799e-01 | 0.109 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.805916e-01 | 0.108 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.813403e-01 | 0.107 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.818265e-01 | 0.107 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.824937e-01 | 0.107 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.847836e-01 | 0.105 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.924444e-01 | 0.101 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.924444e-01 | 0.101 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.924444e-01 | 0.101 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.924444e-01 | 0.101 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.924444e-01 | 0.101 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.924444e-01 | 0.101 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.924444e-01 | 0.101 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.924444e-01 | 0.101 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.924444e-01 | 0.101 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.924444e-01 | 0.101 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.924444e-01 | 0.101 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.924444e-01 | 0.101 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.940143e-01 | 0.100 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.952509e-01 | 0.099 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.952509e-01 | 0.099 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.952509e-01 | 0.099 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.959847e-01 | 0.099 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.981264e-01 | 0.098 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.983070e-01 | 0.098 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.998920e-01 | 0.097 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.998920e-01 | 0.097 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.998920e-01 | 0.097 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.998920e-01 | 0.097 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.998920e-01 | 0.097 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.998920e-01 | 0.097 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.009833e-01 | 0.096 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.011578e-01 | 0.096 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.011578e-01 | 0.096 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.011578e-01 | 0.096 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.011578e-01 | 0.096 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.011578e-01 | 0.096 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.012502e-01 | 0.096 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.012502e-01 | 0.096 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.012502e-01 | 0.096 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.012502e-01 | 0.096 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.085131e-01 | 0.092 | 1 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.141508e-01 | 0.089 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.162475e-01 | 0.088 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.163619e-01 | 0.088 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.186292e-01 | 0.087 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.186292e-01 | 0.087 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.186292e-01 | 0.087 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.186292e-01 | 0.087 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.200994e-01 | 0.086 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.200994e-01 | 0.086 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.200994e-01 | 0.086 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.200994e-01 | 0.086 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.200994e-01 | 0.086 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.200994e-01 | 0.086 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.200994e-01 | 0.086 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.200994e-01 | 0.086 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.215016e-01 | 0.085 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.215016e-01 | 0.085 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.215016e-01 | 0.085 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.215016e-01 | 0.085 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.215016e-01 | 0.085 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.219139e-01 | 0.085 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.219139e-01 | 0.085 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.219139e-01 | 0.085 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.271902e-01 | 0.082 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.275837e-01 | 0.082 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.275837e-01 | 0.082 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.275837e-01 | 0.082 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.302556e-01 | 0.081 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.346971e-01 | 0.078 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.360736e-01 | 0.078 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.360736e-01 | 0.078 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.360736e-01 | 0.078 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.362732e-01 | 0.078 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.399559e-01 | 0.076 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.399559e-01 | 0.076 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.399559e-01 | 0.076 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.411684e-01 | 0.075 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.440710e-01 | 0.074 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.440710e-01 | 0.074 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.440710e-01 | 0.074 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.440710e-01 | 0.074 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.440710e-01 | 0.074 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.440710e-01 | 0.074 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.440710e-01 | 0.074 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.440710e-01 | 0.074 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.440710e-01 | 0.074 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.440710e-01 | 0.074 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.440710e-01 | 0.074 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.440710e-01 | 0.074 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.440710e-01 | 0.074 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.440710e-01 | 0.074 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.440710e-01 | 0.074 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.455986e-01 | 0.073 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.495227e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.495227e-01 | 0.071 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.513879e-01 | 0.070 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.563398e-01 | 0.067 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.566630e-01 | 0.067 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.566630e-01 | 0.067 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.566630e-01 | 0.067 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.566630e-01 | 0.067 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.613055e-01 | 0.065 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.615711e-01 | 0.065 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.615711e-01 | 0.065 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.615711e-01 | 0.065 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.631760e-01 | 0.064 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.631989e-01 | 0.064 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.641039e-01 | 0.063 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.648496e-01 | 0.063 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.648496e-01 | 0.063 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.648496e-01 | 0.063 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.648496e-01 | 0.063 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.648496e-01 | 0.063 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.648496e-01 | 0.063 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.648496e-01 | 0.063 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.648496e-01 | 0.063 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.648496e-01 | 0.063 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.648496e-01 | 0.063 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.648496e-01 | 0.063 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.648496e-01 | 0.063 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.648496e-01 | 0.063 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.648496e-01 | 0.063 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.648496e-01 | 0.063 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.661205e-01 | 0.062 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.664584e-01 | 0.062 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.664584e-01 | 0.062 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.672883e-01 | 0.062 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.705638e-01 | 0.060 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.717608e-01 | 0.060 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.717608e-01 | 0.060 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.717608e-01 | 0.060 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.717608e-01 | 0.060 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.717608e-01 | 0.060 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.725853e-01 | 0.059 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.729956e-01 | 0.059 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.731513e-01 | 0.059 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.740682e-01 | 0.058 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.757272e-01 | 0.058 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.757272e-01 | 0.058 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.798074e-01 | 0.056 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.824874e-01 | 0.054 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.828603e-01 | 0.054 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.828603e-01 | 0.054 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.828603e-01 | 0.054 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.828603e-01 | 0.054 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.828603e-01 | 0.054 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.828603e-01 | 0.054 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 8.828603e-01 | 0.054 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.833360e-01 | 0.054 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.833360e-01 | 0.054 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.835964e-01 | 0.054 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.853813e-01 | 0.053 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.853813e-01 | 0.053 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.853813e-01 | 0.053 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.853813e-01 | 0.053 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.853813e-01 | 0.053 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.853813e-01 | 0.053 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.853813e-01 | 0.053 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.914862e-01 | 0.050 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.976502e-01 | 0.047 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.976502e-01 | 0.047 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.976502e-01 | 0.047 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.977999e-01 | 0.047 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.977999e-01 | 0.047 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.977999e-01 | 0.047 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.979833e-01 | 0.047 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.984718e-01 | 0.046 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.984718e-01 | 0.046 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.984718e-01 | 0.046 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.984718e-01 | 0.046 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.984718e-01 | 0.046 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.984718e-01 | 0.046 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.984718e-01 | 0.046 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.984718e-01 | 0.046 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.984718e-01 | 0.046 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.984718e-01 | 0.046 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.984718e-01 | 0.046 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.086856e-01 | 0.042 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.086856e-01 | 0.042 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.086856e-01 | 0.042 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.086856e-01 | 0.042 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.087579e-01 | 0.042 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.108980e-01 | 0.041 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.108980e-01 | 0.041 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 9.120035e-01 | 0.040 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.120035e-01 | 0.040 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.120035e-01 | 0.040 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.120035e-01 | 0.040 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.120035e-01 | 0.040 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.120035e-01 | 0.040 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.120035e-01 | 0.040 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.144692e-01 | 0.039 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.168272e-01 | 0.038 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.185984e-01 | 0.037 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.185984e-01 | 0.037 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.186424e-01 | 0.037 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.186424e-01 | 0.037 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.186424e-01 | 0.037 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.190264e-01 | 0.037 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.225937e-01 | 0.035 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.228835e-01 | 0.035 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.228835e-01 | 0.035 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.237323e-01 | 0.034 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 9.237323e-01 | 0.034 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.237323e-01 | 0.034 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.237323e-01 | 0.034 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.237323e-01 | 0.034 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.237323e-01 | 0.034 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.237323e-01 | 0.034 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.237323e-01 | 0.034 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.237323e-01 | 0.034 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.237323e-01 | 0.034 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.243245e-01 | 0.034 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.257782e-01 | 0.033 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.274918e-01 | 0.033 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.274918e-01 | 0.033 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.274918e-01 | 0.033 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.274918e-01 | 0.033 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.291913e-01 | 0.032 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.316572e-01 | 0.031 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.316572e-01 | 0.031 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.338984e-01 | 0.030 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.338984e-01 | 0.030 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.338984e-01 | 0.030 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.338984e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.338984e-01 | 0.030 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.338984e-01 | 0.030 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.338984e-01 | 0.030 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.338984e-01 | 0.030 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 9.338984e-01 | 0.030 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.338984e-01 | 0.030 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.338984e-01 | 0.030 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.354613e-01 | 0.029 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.354613e-01 | 0.029 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.383303e-01 | 0.028 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.383814e-01 | 0.028 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.404426e-01 | 0.027 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.425951e-01 | 0.026 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.425951e-01 | 0.026 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.425951e-01 | 0.026 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.425951e-01 | 0.026 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.427100e-01 | 0.026 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.427100e-01 | 0.026 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.427100e-01 | 0.026 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.427100e-01 | 0.026 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.427100e-01 | 0.026 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.427100e-01 | 0.026 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.427100e-01 | 0.026 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.427492e-01 | 0.026 | 1 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.439236e-01 | 0.025 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.443958e-01 | 0.025 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.443958e-01 | 0.025 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.443958e-01 | 0.025 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.443958e-01 | 0.025 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.479405e-01 | 0.023 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.489744e-01 | 0.023 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.489744e-01 | 0.023 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.489744e-01 | 0.023 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.497754e-01 | 0.022 | 1 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.499031e-01 | 0.022 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.499031e-01 | 0.022 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.500576e-01 | 0.022 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.502833e-01 | 0.022 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.503474e-01 | 0.022 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.503474e-01 | 0.022 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.503474e-01 | 0.022 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.503474e-01 | 0.022 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.503474e-01 | 0.022 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.503474e-01 | 0.022 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.503474e-01 | 0.022 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.503474e-01 | 0.022 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.503474e-01 | 0.022 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.503474e-01 | 0.022 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.504092e-01 | 0.022 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.539167e-01 | 0.020 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.543161e-01 | 0.020 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.546736e-01 | 0.020 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.546736e-01 | 0.020 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.546736e-01 | 0.020 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.548981e-01 | 0.020 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.559710e-01 | 0.020 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.569670e-01 | 0.019 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.569670e-01 | 0.019 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.569670e-01 | 0.019 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.569670e-01 | 0.019 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.569670e-01 | 0.019 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.569670e-01 | 0.019 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.569670e-01 | 0.019 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.569670e-01 | 0.019 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.581458e-01 | 0.019 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.594238e-01 | 0.018 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.597604e-01 | 0.018 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.597604e-01 | 0.018 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.597604e-01 | 0.018 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.605655e-01 | 0.017 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.613950e-01 | 0.017 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.627044e-01 | 0.017 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.627044e-01 | 0.017 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.627044e-01 | 0.017 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.627044e-01 | 0.017 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.635204e-01 | 0.016 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.635204e-01 | 0.016 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.642970e-01 | 0.016 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.642970e-01 | 0.016 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.642970e-01 | 0.016 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.644142e-01 | 0.016 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.653820e-01 | 0.015 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.663689e-01 | 0.015 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.676772e-01 | 0.014 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.676772e-01 | 0.014 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.676772e-01 | 0.014 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.682346e-01 | 0.014 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.683396e-01 | 0.014 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.683396e-01 | 0.014 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.702358e-01 | 0.013 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.705724e-01 | 0.013 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.705724e-01 | 0.013 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.705724e-01 | 0.013 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.715929e-01 | 0.013 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.719871e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.719871e-01 | 0.012 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.719871e-01 | 0.012 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.719871e-01 | 0.012 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.719871e-01 | 0.012 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.735941e-01 | 0.012 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.735941e-01 | 0.012 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.751420e-01 | 0.011 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.751420e-01 | 0.011 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.757226e-01 | 0.011 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.757226e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.757226e-01 | 0.011 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.759481e-01 | 0.011 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.763197e-01 | 0.010 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.763197e-01 | 0.010 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.787762e-01 | 0.009 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.789602e-01 | 0.009 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.789602e-01 | 0.009 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.789602e-01 | 0.009 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.789602e-01 | 0.009 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.789602e-01 | 0.009 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.789602e-01 | 0.009 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.789602e-01 | 0.009 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.805204e-01 | 0.009 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.805204e-01 | 0.009 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.805204e-01 | 0.009 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.805204e-01 | 0.009 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.809885e-01 | 0.008 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.809885e-01 | 0.008 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.809885e-01 | 0.008 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.810133e-01 | 0.008 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.817662e-01 | 0.008 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.817662e-01 | 0.008 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.817662e-01 | 0.008 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.817662e-01 | 0.008 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.827677e-01 | 0.008 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.827677e-01 | 0.008 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.829795e-01 | 0.007 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.832521e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.832521e-01 | 0.007 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.841981e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.841981e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.841981e-01 | 0.007 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.841981e-01 | 0.007 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.841981e-01 | 0.007 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.841981e-01 | 0.007 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.847622e-01 | 0.007 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.847700e-01 | 0.007 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.860490e-01 | 0.006 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.863057e-01 | 0.006 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.863057e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.863790e-01 | 0.006 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.863790e-01 | 0.006 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.865313e-01 | 0.006 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.865313e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.865313e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.865313e-01 | 0.006 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.871926e-01 | 0.006 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.877308e-01 | 0.005 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.880998e-01 | 0.005 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.880998e-01 | 0.005 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.881324e-01 | 0.005 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.881324e-01 | 0.005 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.886701e-01 | 0.005 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.886701e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.887882e-01 | 0.005 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.890664e-01 | 0.005 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.891854e-01 | 0.005 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.894460e-01 | 0.005 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.894896e-01 | 0.005 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.894896e-01 | 0.005 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.894896e-01 | 0.005 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.897155e-01 | 0.004 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.897155e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.897974e-01 | 0.004 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.898468e-01 | 0.004 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.901962e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.907204e-01 | 0.004 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.910875e-01 | 0.004 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.910875e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.910875e-01 | 0.004 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.910875e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.910875e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.910875e-01 | 0.004 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.910875e-01 | 0.004 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.914809e-01 | 0.004 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.917388e-01 | 0.004 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.918100e-01 | 0.004 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.918100e-01 | 0.004 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.918100e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.918156e-01 | 0.004 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.922617e-01 | 0.003 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.922765e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.927741e-01 | 0.003 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.927741e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.930913e-01 | 0.003 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.930929e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.930929e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.933069e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.933069e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.933232e-01 | 0.003 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.936268e-01 | 0.003 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.936784e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.938900e-01 | 0.003 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.942000e-01 | 0.003 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.942000e-01 | 0.003 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.942765e-01 | 0.002 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.943698e-01 | 0.002 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.943807e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.946133e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.947164e-01 | 0.002 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.947985e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.949739e-01 | 0.002 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.955833e-01 | 0.002 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.956354e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.956354e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.956354e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.956354e-01 | 0.002 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.956446e-01 | 0.002 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.956446e-01 | 0.002 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.956507e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.957100e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.961088e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.961286e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.961286e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.962258e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.963346e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.965114e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.965552e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.965552e-01 | 0.001 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.965552e-01 | 0.001 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.965803e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.966139e-01 | 0.001 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.967295e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.967295e-01 | 0.001 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.967295e-01 | 0.001 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.967295e-01 | 0.001 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.967295e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.969359e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.969925e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.971660e-01 | 0.001 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.971660e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.971992e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.974918e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.975443e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.975443e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.975544e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.976907e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.978721e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.978745e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.979683e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.981561e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.981561e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.981561e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.982026e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.982371e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.984023e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.984286e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.984931e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.984931e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.985366e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.986156e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.986156e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.986156e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.986437e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.987857e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.989476e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.989606e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.990624e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.990668e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.990668e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.990994e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.992067e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.993222e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.993238e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.993503e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.993648e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.994141e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.994141e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.994246e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.994424e-01 | 0.000 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.994924e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.995182e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.995602e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.995650e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.995898e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.996154e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.996189e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.996231e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.996231e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996783e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.997139e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.997139e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.997451e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997456e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997456e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997745e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.997853e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.998286e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998286e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998497e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998682e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998736e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.998790e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998846e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.998952e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998952e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.999318e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999318e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.999318e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999394e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.999410e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999601e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999613e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999616e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999616e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999707e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999712e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999733e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999761e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999843e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999863e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999893e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999895e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999902e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999909e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999939e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999947e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999957e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999961e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999970e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999971e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999987e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999987e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999987e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999988e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999989e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999992e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999993e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999993e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999996e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.665335e-15 | 14.778 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.210143e-14 | 13.917 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.264855e-14 | 13.645 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.458656e-13 | 12.351 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.044387e-12 | 11.981 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.644063e-12 | 11.016 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.252520e-11 | 10.647 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.252520e-11 | 10.647 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.977629e-11 | 10.704 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.266198e-11 | 10.645 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.534006e-11 | 10.452 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.710210e-11 | 10.431 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.941469e-11 | 10.404 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.941469e-11 | 10.404 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.952028e-11 | 10.403 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.254554e-10 | 9.902 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.450137e-10 | 9.839 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.005675e-10 | 9.698 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.256537e-10 | 9.647 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.697963e-10 | 9.569 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.022501e-10 | 9.520 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.230056e-10 | 9.491 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.087225e-10 | 9.389 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.975205e-10 | 9.401 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.305967e-10 | 9.366 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.041784e-10 | 9.219 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.570359e-10 | 9.121 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.817588e-10 | 9.107 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.061967e-09 | 8.974 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.091287e-09 | 8.962 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.278441e-09 | 8.893 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.289601e-09 | 8.890 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.541648e-09 | 8.812 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.607499e-09 | 8.794 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.684714e-09 | 8.773 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.678746e-09 | 8.775 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.821607e-09 | 8.740 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.983395e-09 | 8.703 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.432080e-09 | 8.614 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.712436e-09 | 8.567 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.542868e-09 | 8.451 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.839509e-09 | 8.416 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.785038e-09 | 8.422 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.887167e-09 | 8.311 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.395189e-09 | 8.268 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.460108e-09 | 8.263 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.640282e-09 | 8.249 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.640282e-09 | 8.249 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.499969e-09 | 8.187 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.740507e-09 | 8.171 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.210242e-09 | 8.142 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.083399e-09 | 8.092 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.581230e-09 | 8.066 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.744843e-09 | 8.058 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.094581e-09 | 8.041 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.021055e-08 | 7.991 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.076551e-08 | 7.968 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.139547e-08 | 7.943 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.199545e-08 | 7.921 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.185611e-08 | 7.926 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.371193e-08 | 7.863 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.540716e-08 | 7.812 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.624837e-08 | 7.789 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.714282e-08 | 7.766 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.763382e-08 | 7.754 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.806860e-08 | 7.743 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.003071e-08 | 7.698 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.148847e-08 | 7.668 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.347085e-08 | 7.629 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.456926e-08 | 7.610 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.478484e-08 | 7.606 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.386419e-08 | 7.470 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.557084e-08 | 7.449 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.700123e-08 | 7.432 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.950029e-08 | 7.403 | 1 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.285864e-08 | 7.368 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.374167e-08 | 7.359 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.475912e-08 | 7.349 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.446661e-08 | 7.264 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.207805e-08 | 7.283 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.761701e-08 | 7.170 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.896165e-08 | 7.161 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.143520e-08 | 7.146 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.484252e-08 | 7.126 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.002730e-08 | 7.097 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.002730e-08 | 7.097 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.577942e-08 | 7.067 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.577942e-08 | 7.067 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.823168e-08 | 7.054 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.823168e-08 | 7.054 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.871264e-08 | 7.052 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.101355e-07 | 6.958 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.113856e-07 | 6.953 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.151810e-07 | 6.939 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.177780e-07 | 6.929 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.295977e-07 | 6.887 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.345536e-07 | 6.871 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.390738e-07 | 6.857 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.535658e-07 | 6.814 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.566575e-07 | 6.805 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.635124e-07 | 6.786 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.658483e-07 | 6.780 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.348942e-07 | 6.629 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.627267e-07 | 6.580 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.855249e-07 | 6.544 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.897883e-07 | 6.538 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.946253e-07 | 6.531 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.946253e-07 | 6.531 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.257289e-07 | 6.487 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.207894e-07 | 6.494 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.426966e-07 | 6.465 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.444518e-07 | 6.463 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.765754e-07 | 6.424 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.939593e-07 | 6.405 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.120785e-07 | 6.385 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.681041e-07 | 6.330 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.534067e-07 | 6.344 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.844479e-07 | 6.315 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.065020e-07 | 6.295 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.953877e-07 | 6.225 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.703841e-07 | 6.174 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.703841e-07 | 6.174 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.059000e-07 | 6.151 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.812767e-07 | 6.107 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.087304e-07 | 6.042 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.536206e-07 | 6.021 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.056952e-06 | 5.976 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.169849e-06 | 5.932 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.449446e-06 | 5.839 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.523601e-06 | 5.817 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.558163e-06 | 5.807 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.600601e-06 | 5.796 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.605907e-06 | 5.794 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.832394e-06 | 5.737 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.800007e-06 | 5.745 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.827398e-06 | 5.738 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.859475e-06 | 5.731 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.971402e-06 | 5.705 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.095323e-06 | 5.679 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.186317e-06 | 5.660 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.339599e-06 | 5.631 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.366771e-06 | 5.626 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.466312e-06 | 5.608 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.597943e-06 | 5.585 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.782677e-06 | 5.556 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.079121e-06 | 5.512 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.465086e-06 | 5.460 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.273401e-06 | 5.485 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.343899e-06 | 5.476 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.747073e-06 | 5.426 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.823096e-06 | 5.418 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.191050e-06 | 5.378 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.583448e-06 | 5.339 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.723582e-06 | 5.326 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.763417e-06 | 5.322 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.041969e-06 | 5.297 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.170566e-06 | 5.286 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.170566e-06 | 5.286 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.792050e-06 | 5.237 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.804682e-06 | 5.236 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.131365e-06 | 5.212 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.337795e-06 | 5.198 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.913650e-06 | 5.102 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.995815e-06 | 5.097 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.429989e-06 | 5.074 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.520849e-06 | 5.070 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.871200e-06 | 5.052 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.038283e-05 | 4.984 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.157801e-05 | 4.936 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.241880e-05 | 4.906 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.270271e-05 | 4.896 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.432601e-05 | 4.844 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.737763e-05 | 4.760 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.983403e-05 | 4.703 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.490355e-05 | 4.604 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.558591e-05 | 4.592 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.775337e-05 | 4.557 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.075640e-05 | 4.512 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.270162e-05 | 4.485 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.290214e-05 | 4.483 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.862452e-05 | 4.413 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.186148e-05 | 4.378 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.506592e-05 | 4.346 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.644852e-05 | 4.333 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.078718e-05 | 4.294 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.121008e-05 | 4.291 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.995946e-05 | 4.222 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.995946e-05 | 4.222 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.478585e-05 | 4.189 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.717881e-05 | 4.173 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.752327e-05 | 4.171 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.250674e-05 | 4.140 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.041267e-05 | 4.152 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.913920e-05 | 4.102 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.774412e-05 | 4.109 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.450602e-05 | 4.073 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.642699e-05 | 4.063 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.870696e-05 | 4.052 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.574910e-05 | 4.019 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.594625e-05 | 4.018 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.778679e-05 | 4.010 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.043482e-04 | 3.982 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.088897e-04 | 3.963 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.168194e-04 | 3.932 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.250434e-04 | 3.903 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.317522e-04 | 3.880 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.324245e-04 | 3.878 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.376123e-04 | 3.861 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.376561e-04 | 3.861 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.444632e-04 | 3.840 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.555909e-04 | 3.808 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.555909e-04 | 3.808 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.571155e-04 | 3.804 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.631899e-04 | 3.787 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.747864e-04 | 3.757 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.848643e-04 | 3.733 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.839092e-04 | 3.735 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.733537e-04 | 3.761 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.197208e-04 | 3.658 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.224598e-04 | 3.653 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.412017e-04 | 3.618 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.451173e-04 | 3.611 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.451173e-04 | 3.611 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.451173e-04 | 3.611 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.561394e-04 | 3.592 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.976660e-04 | 3.526 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.293974e-04 | 3.482 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.825503e-04 | 3.417 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.938850e-04 | 3.405 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.377952e-04 | 3.359 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.472974e-04 | 3.349 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.479987e-04 | 3.349 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.502755e-04 | 3.347 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.502755e-04 | 3.347 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.547089e-04 | 3.342 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.634974e-04 | 3.334 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.007308e-04 | 3.300 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.920582e-04 | 3.228 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.066298e-04 | 3.217 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.066298e-04 | 3.217 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.553319e-04 | 3.184 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.622295e-04 | 3.179 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.892286e-04 | 3.162 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.997708e-04 | 3.155 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.626777e-04 | 3.118 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.225663e-04 | 3.141 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.140132e-04 | 3.146 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.532347e-04 | 3.123 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.736114e-04 | 3.111 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.269612e-04 | 3.083 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.400843e-04 | 3.131 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.301510e-04 | 3.137 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.442624e-04 | 3.074 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.027710e-03 | 2.988 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.027710e-03 | 2.988 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.061882e-03 | 2.974 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.062214e-03 | 2.974 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.109988e-03 | 2.955 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.115495e-03 | 2.953 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.134130e-03 | 2.945 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.218439e-03 | 2.914 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.243532e-03 | 2.905 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.282616e-03 | 2.892 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.336097e-03 | 2.874 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.435239e-03 | 2.843 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.470847e-03 | 2.832 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.472292e-03 | 2.832 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.482613e-03 | 2.829 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.482613e-03 | 2.829 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.496042e-03 | 2.825 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.496042e-03 | 2.825 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.601512e-03 | 2.795 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.638524e-03 | 2.786 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.645229e-03 | 2.784 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.695264e-03 | 2.771 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.808934e-03 | 2.743 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.808934e-03 | 2.743 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.839028e-03 | 2.735 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.929685e-03 | 2.715 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.006266e-03 | 2.698 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.123781e-03 | 2.673 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.123781e-03 | 2.673 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.130173e-03 | 2.672 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.359394e-03 | 2.627 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.576240e-03 | 2.589 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.576240e-03 | 2.589 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.467276e-03 | 2.608 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.852145e-03 | 2.545 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.597708e-03 | 2.585 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.811820e-03 | 2.551 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.573876e-03 | 2.589 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.573876e-03 | 2.589 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.864442e-03 | 2.543 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.971824e-03 | 2.527 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.971824e-03 | 2.527 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.971824e-03 | 2.527 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.971824e-03 | 2.527 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.048147e-03 | 2.516 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.218038e-03 | 2.492 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.223334e-03 | 2.492 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.281391e-03 | 2.484 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.327338e-03 | 2.478 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.346630e-03 | 2.475 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.398379e-03 | 2.469 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.398379e-03 | 2.469 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.398379e-03 | 2.469 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.398379e-03 | 2.469 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.398379e-03 | 2.469 | 0 | 0 |
| Translation | R-HSA-72766 | 3.507331e-03 | 2.455 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.880079e-03 | 2.411 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.880079e-03 | 2.411 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.880079e-03 | 2.411 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.922320e-03 | 2.406 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.922320e-03 | 2.406 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.945423e-03 | 2.404 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.010430e-03 | 2.397 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.504462e-03 | 2.346 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.504462e-03 | 2.346 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 4.504462e-03 | 2.346 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.504462e-03 | 2.346 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.728671e-03 | 2.325 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.728671e-03 | 2.325 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.769946e-03 | 2.321 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.071526e-03 | 2.295 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.199179e-03 | 2.284 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.365468e-03 | 2.270 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.585726e-03 | 2.253 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.823068e-03 | 2.235 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.917201e-03 | 2.228 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.199674e-03 | 2.208 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.305356e-03 | 2.200 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.323051e-03 | 2.199 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.374348e-03 | 2.196 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.374348e-03 | 2.196 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.397084e-03 | 2.194 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.397084e-03 | 2.194 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.406444e-03 | 2.193 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.856688e-03 | 2.164 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.187338e-03 | 2.143 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.188262e-03 | 2.143 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.345311e-03 | 2.134 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.405170e-03 | 2.130 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.637990e-03 | 2.117 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.649549e-03 | 2.063 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.534804e-03 | 2.069 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.758822e-03 | 2.058 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.758822e-03 | 2.058 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.492921e-03 | 2.023 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.068361e-03 | 2.093 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.033998e-03 | 2.044 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.398269e-03 | 2.076 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.703068e-03 | 2.013 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.565157e-03 | 2.019 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.795530e-03 | 2.009 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.936119e-03 | 2.003 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.012614e-02 | 1.995 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.054385e-02 | 1.977 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.081262e-02 | 1.966 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.081262e-02 | 1.966 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.081262e-02 | 1.966 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.084695e-02 | 1.965 | 1 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.107480e-02 | 1.956 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.119709e-02 | 1.951 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.138179e-02 | 1.944 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.140341e-02 | 1.943 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.140341e-02 | 1.943 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.157200e-02 | 1.937 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.197130e-02 | 1.922 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.202216e-02 | 1.920 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.202216e-02 | 1.920 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.202216e-02 | 1.920 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.213249e-02 | 1.916 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.213249e-02 | 1.916 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.327551e-02 | 1.877 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.343733e-02 | 1.872 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.344248e-02 | 1.872 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.365232e-02 | 1.865 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.365232e-02 | 1.865 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.379609e-02 | 1.860 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.436969e-02 | 1.843 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.478681e-02 | 1.830 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.478681e-02 | 1.830 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.505089e-02 | 1.822 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.505089e-02 | 1.822 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.516405e-02 | 1.819 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.520283e-02 | 1.818 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.557741e-02 | 1.808 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.573005e-02 | 1.803 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.606718e-02 | 1.794 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.607340e-02 | 1.794 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.634589e-02 | 1.787 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.049650e-02 | 1.688 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.049650e-02 | 1.688 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.049650e-02 | 1.688 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.049650e-02 | 1.688 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.049650e-02 | 1.688 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.049650e-02 | 1.688 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.792511e-02 | 1.747 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.792511e-02 | 1.747 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.904367e-02 | 1.720 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.904367e-02 | 1.720 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.744768e-02 | 1.758 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.744768e-02 | 1.758 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.202314e-02 | 1.657 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.886299e-02 | 1.724 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.886299e-02 | 1.724 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.199549e-02 | 1.658 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.199549e-02 | 1.658 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.861813e-02 | 1.730 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.861813e-02 | 1.730 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.724936e-02 | 1.763 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.199549e-02 | 1.658 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.744768e-02 | 1.758 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.744768e-02 | 1.758 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.803622e-02 | 1.744 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.724936e-02 | 1.763 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.803622e-02 | 1.744 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.841016e-02 | 1.735 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.724936e-02 | 1.763 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.863801e-02 | 1.730 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.861813e-02 | 1.730 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.120687e-02 | 1.674 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.711046e-02 | 1.767 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.904367e-02 | 1.720 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.921939e-02 | 1.716 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.070744e-02 | 1.684 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.841016e-02 | 1.735 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.963617e-02 | 1.707 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.720799e-02 | 1.764 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.214426e-02 | 1.655 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.232690e-02 | 1.651 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.370376e-02 | 1.625 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.384921e-02 | 1.623 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.391305e-02 | 1.621 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.446486e-02 | 1.611 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.457562e-02 | 1.609 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.480163e-02 | 1.606 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.482166e-02 | 1.605 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.482166e-02 | 1.605 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.482166e-02 | 1.605 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.482166e-02 | 1.605 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.542492e-02 | 1.595 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.549405e-02 | 1.594 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.578533e-02 | 1.589 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.630374e-02 | 1.580 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.733291e-02 | 1.563 | 1 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.801981e-02 | 1.553 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.907162e-02 | 1.537 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.934756e-02 | 1.532 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.934756e-02 | 1.532 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.981571e-02 | 1.526 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.023561e-02 | 1.519 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.033846e-02 | 1.518 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.033846e-02 | 1.518 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.095702e-02 | 1.509 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.136915e-02 | 1.503 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.144838e-02 | 1.502 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.179401e-02 | 1.498 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.185927e-02 | 1.497 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.220478e-02 | 1.492 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.220478e-02 | 1.492 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.220478e-02 | 1.492 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.220478e-02 | 1.492 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.220478e-02 | 1.492 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.220478e-02 | 1.492 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.343849e-02 | 1.476 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.343849e-02 | 1.476 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.343849e-02 | 1.476 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.343849e-02 | 1.476 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.343849e-02 | 1.476 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.360276e-02 | 1.474 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.360276e-02 | 1.474 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.504064e-02 | 1.455 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.504064e-02 | 1.455 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.507742e-02 | 1.455 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.605102e-02 | 1.443 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.826555e-02 | 1.417 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.826555e-02 | 1.417 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.826555e-02 | 1.417 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.826555e-02 | 1.417 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.826555e-02 | 1.417 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.826555e-02 | 1.417 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.830515e-02 | 1.417 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.858039e-02 | 1.414 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.001426e-02 | 1.398 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.001426e-02 | 1.398 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.033687e-02 | 1.394 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.033687e-02 | 1.394 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.033687e-02 | 1.394 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.168226e-02 | 1.380 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.202457e-02 | 1.376 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.203592e-02 | 1.376 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.206145e-02 | 1.376 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.206145e-02 | 1.376 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.236095e-02 | 1.373 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.296542e-02 | 1.367 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.335009e-02 | 1.363 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.359237e-02 | 1.361 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.802679e-02 | 1.236 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.802679e-02 | 1.236 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.528859e-02 | 1.257 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.528859e-02 | 1.257 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.528859e-02 | 1.257 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.880910e-02 | 1.231 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.880910e-02 | 1.231 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.973200e-02 | 1.303 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.820700e-02 | 1.235 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.820700e-02 | 1.235 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.820700e-02 | 1.235 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.820700e-02 | 1.235 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.820700e-02 | 1.235 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.749309e-02 | 1.171 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.246407e-02 | 1.280 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.671231e-02 | 1.176 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.671231e-02 | 1.176 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.134848e-02 | 1.289 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.654080e-02 | 1.248 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.570635e-02 | 1.254 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.829773e-02 | 1.234 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.857530e-02 | 1.314 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.749309e-02 | 1.171 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.896472e-02 | 1.229 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.671231e-02 | 1.176 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.063297e-02 | 1.217 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.880910e-02 | 1.231 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.991088e-02 | 1.302 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.614024e-02 | 1.336 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.845446e-02 | 1.315 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.845446e-02 | 1.315 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.887844e-02 | 1.311 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.887844e-02 | 1.311 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.880910e-02 | 1.231 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.368728e-02 | 1.196 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.931887e-02 | 1.227 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.646469e-02 | 1.248 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.516581e-02 | 1.345 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.671231e-02 | 1.176 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.668307e-02 | 1.331 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.629451e-02 | 1.250 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.845446e-02 | 1.315 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.886880e-02 | 1.311 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.710748e-02 | 1.327 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.508431e-02 | 1.346 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.368728e-02 | 1.196 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.483225e-02 | 1.261 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.712070e-02 | 1.173 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.802679e-02 | 1.236 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.749309e-02 | 1.171 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.671231e-02 | 1.176 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.886880e-02 | 1.311 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.557485e-02 | 1.255 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.802679e-02 | 1.236 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.709664e-02 | 1.243 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.445903e-02 | 1.191 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.702827e-02 | 1.174 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.160146e-02 | 1.287 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.574750e-02 | 1.254 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.749309e-02 | 1.171 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.390932e-02 | 1.268 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.519444e-02 | 1.345 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.880910e-02 | 1.231 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.377955e-02 | 1.269 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.528859e-02 | 1.257 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.880910e-02 | 1.231 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.528859e-02 | 1.257 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.766476e-02 | 1.170 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.804420e-02 | 1.167 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.804420e-02 | 1.167 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.845564e-02 | 1.165 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.845564e-02 | 1.165 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.980517e-02 | 1.156 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.980517e-02 | 1.156 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.980517e-02 | 1.156 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.980517e-02 | 1.156 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.980517e-02 | 1.156 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.980517e-02 | 1.156 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.121131e-02 | 1.147 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 7.121131e-02 | 1.147 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.121131e-02 | 1.147 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 7.121131e-02 | 1.147 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 7.121131e-02 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.121131e-02 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.121131e-02 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.121131e-02 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.121131e-02 | 1.147 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.121131e-02 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.121131e-02 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.121131e-02 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.121131e-02 | 1.147 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.121131e-02 | 1.147 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.133988e-02 | 1.147 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.227897e-02 | 1.141 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.227897e-02 | 1.141 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.436756e-02 | 1.129 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.526081e-02 | 1.123 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.546700e-02 | 1.122 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.627137e-02 | 1.118 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.758990e-02 | 1.110 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.758990e-02 | 1.110 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.758990e-02 | 1.110 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.048109e-02 | 1.094 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.048109e-02 | 1.094 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.185345e-02 | 1.087 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.185345e-02 | 1.087 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.313092e-02 | 1.080 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.313092e-02 | 1.080 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.319425e-02 | 1.080 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.319425e-02 | 1.080 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.319425e-02 | 1.080 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.327501e-02 | 1.079 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.327501e-02 | 1.079 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.327501e-02 | 1.079 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.327501e-02 | 1.079 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.643558e-02 | 1.063 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.809673e-02 | 1.055 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.849023e-02 | 1.053 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.915556e-02 | 1.050 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.009401e-02 | 1.045 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.141705e-02 | 1.039 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.155008e-02 | 1.038 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.202774e-02 | 1.036 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.215662e-02 | 1.035 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.261864e-02 | 1.033 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.450263e-02 | 1.025 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.492944e-02 | 1.023 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.492944e-02 | 1.023 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.550494e-02 | 1.020 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.625419e-02 | 1.017 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.625419e-02 | 1.017 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.712170e-02 | 1.013 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.712170e-02 | 1.013 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 9.712170e-02 | 1.013 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.750919e-02 | 1.011 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 9.928951e-02 | 1.003 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.928951e-02 | 1.003 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.928951e-02 | 1.003 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.928951e-02 | 1.003 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.928951e-02 | 1.003 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.001804e-01 | 0.999 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.019522e-01 | 0.992 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.030929e-01 | 0.987 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.030929e-01 | 0.987 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.038056e-01 | 0.984 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.038056e-01 | 0.984 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.038056e-01 | 0.984 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.059205e-01 | 0.975 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.073180e-01 | 0.969 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.075235e-01 | 0.968 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.089984e-01 | 0.963 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.089984e-01 | 0.963 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.089984e-01 | 0.963 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.089984e-01 | 0.963 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.094917e-01 | 0.961 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.094917e-01 | 0.961 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.114052e-01 | 0.953 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.118034e-01 | 0.952 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.118201e-01 | 0.951 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.118201e-01 | 0.951 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.131171e-01 | 0.946 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.153948e-01 | 0.938 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.167059e-01 | 0.933 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.167059e-01 | 0.933 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.167059e-01 | 0.933 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.167059e-01 | 0.933 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.180372e-01 | 0.928 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.197593e-01 | 0.922 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.197593e-01 | 0.922 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.197593e-01 | 0.922 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.198921e-01 | 0.921 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.198921e-01 | 0.921 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.955631e-01 | 0.709 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.955631e-01 | 0.709 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.955631e-01 | 0.709 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.955631e-01 | 0.709 | 0 | 0 |
| Defective GALM causes GALAC4 | R-HSA-9931929 | 1.955631e-01 | 0.709 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.955631e-01 | 0.709 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.395525e-01 | 0.855 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.774565e-01 | 0.751 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.774565e-01 | 0.751 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 1.774565e-01 | 0.751 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.774565e-01 | 0.751 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.441182e-01 | 0.841 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.441182e-01 | 0.841 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.441182e-01 | 0.841 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.441182e-01 | 0.841 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.166935e-01 | 0.664 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.166935e-01 | 0.664 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.166935e-01 | 0.664 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.166935e-01 | 0.664 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.699341e-01 | 0.770 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.699341e-01 | 0.770 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.699341e-01 | 0.770 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.969451e-01 | 0.706 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.550977e-01 | 0.809 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.240164e-01 | 0.907 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.399318e-01 | 0.854 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.399318e-01 | 0.854 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.399318e-01 | 0.854 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.758477e-01 | 0.755 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.758477e-01 | 0.755 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.248970e-01 | 0.648 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.248970e-01 | 0.648 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.248970e-01 | 0.648 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.258455e-01 | 0.900 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.974737e-01 | 0.704 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.974737e-01 | 0.704 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.543620e-01 | 0.811 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.198521e-01 | 0.658 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.198521e-01 | 0.658 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.924492e-01 | 0.716 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.695990e-01 | 0.771 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.695990e-01 | 0.771 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.854327e-01 | 0.732 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.854327e-01 | 0.732 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.637099e-01 | 0.786 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.240460e-01 | 0.650 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.272509e-01 | 0.643 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.566858e-01 | 0.805 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 1.698700e-01 | 0.770 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.452000e-01 | 0.838 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.699341e-01 | 0.770 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.924492e-01 | 0.716 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.974737e-01 | 0.704 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.360450e-01 | 0.627 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.699341e-01 | 0.770 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.550977e-01 | 0.809 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.924492e-01 | 0.716 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.621353e-01 | 0.790 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.496587e-01 | 0.825 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.112247e-01 | 0.675 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.395525e-01 | 0.855 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.395525e-01 | 0.855 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.974737e-01 | 0.704 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.372702e-01 | 0.862 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.878291e-01 | 0.726 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.240164e-01 | 0.907 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.248970e-01 | 0.648 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.071750e-01 | 0.684 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.052153e-01 | 0.688 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.395525e-01 | 0.855 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.441182e-01 | 0.841 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.258455e-01 | 0.900 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.113183e-01 | 0.675 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.018173e-01 | 0.695 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.242623e-01 | 0.649 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.653822e-01 | 0.782 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.039973e-01 | 0.690 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.974737e-01 | 0.704 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.240164e-01 | 0.907 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.399318e-01 | 0.854 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.969451e-01 | 0.706 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.307477e-01 | 0.637 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.419407e-01 | 0.848 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.777215e-01 | 0.750 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.224412e-01 | 0.912 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.360450e-01 | 0.627 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.828719e-01 | 0.738 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.258455e-01 | 0.900 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.828719e-01 | 0.738 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.774565e-01 | 0.751 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.777215e-01 | 0.750 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.922209e-01 | 0.716 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.240460e-01 | 0.650 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.550977e-01 | 0.809 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.637099e-01 | 0.786 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.224412e-01 | 0.912 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.922209e-01 | 0.716 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.699341e-01 | 0.770 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.758477e-01 | 0.755 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.955631e-01 | 0.709 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.774565e-01 | 0.751 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.550977e-01 | 0.809 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.198521e-01 | 0.658 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.637099e-01 | 0.786 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.292518e-01 | 0.889 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.292518e-01 | 0.889 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.324517e-01 | 0.634 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.867909e-01 | 0.729 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.677522e-01 | 0.775 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.359211e-01 | 0.867 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 1.335728e-01 | 0.874 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.100936e-01 | 0.678 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.379176e-01 | 0.860 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.924492e-01 | 0.716 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.258455e-01 | 0.900 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.674832e-01 | 0.776 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.397644e-01 | 0.855 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.307477e-01 | 0.637 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 2.387667e-01 | 0.622 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.503483e-01 | 0.823 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.974737e-01 | 0.704 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.404221e-01 | 0.853 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.407145e-01 | 0.618 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.353449e-01 | 0.869 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.969451e-01 | 0.706 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.258455e-01 | 0.900 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.347298e-01 | 0.629 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.299339e-01 | 0.638 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.366614e-01 | 0.626 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.694460e-01 | 0.771 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.448241e-01 | 0.839 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.379176e-01 | 0.860 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.507581e-01 | 0.822 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.448241e-01 | 0.839 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.448241e-01 | 0.839 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.685807e-01 | 0.773 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.258455e-01 | 0.900 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.258455e-01 | 0.900 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.757746e-01 | 0.755 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.317825e-01 | 0.880 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.187047e-01 | 0.660 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.401415e-01 | 0.620 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.958887e-01 | 0.708 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.742145e-01 | 0.759 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.667294e-01 | 0.778 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.097381e-01 | 0.678 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.452000e-01 | 0.838 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.292518e-01 | 0.889 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.442610e-01 | 0.841 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.347298e-01 | 0.629 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.985764e-01 | 0.702 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.100936e-01 | 0.678 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.543620e-01 | 0.811 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.242623e-01 | 0.649 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.113183e-01 | 0.675 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.985764e-01 | 0.702 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.774565e-01 | 0.751 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.774565e-01 | 0.751 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.166935e-01 | 0.664 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.113183e-01 | 0.675 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.383075e-01 | 0.623 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.442519e-01 | 0.841 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.387667e-01 | 0.622 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.166935e-01 | 0.664 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.974737e-01 | 0.704 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.924492e-01 | 0.716 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.698700e-01 | 0.770 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.969451e-01 | 0.706 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.359211e-01 | 0.867 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.198521e-01 | 0.658 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.428589e-01 | 0.615 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.428589e-01 | 0.615 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.444278e-01 | 0.612 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.468418e-01 | 0.608 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.506621e-01 | 0.601 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.535479e-01 | 0.596 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.535479e-01 | 0.596 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.535479e-01 | 0.596 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.535479e-01 | 0.596 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.535479e-01 | 0.596 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.535479e-01 | 0.596 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.537871e-01 | 0.596 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.537871e-01 | 0.596 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.537871e-01 | 0.596 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.537871e-01 | 0.596 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.537871e-01 | 0.596 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 2.565863e-01 | 0.591 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.565863e-01 | 0.591 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.565863e-01 | 0.591 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.565863e-01 | 0.591 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.565863e-01 | 0.591 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.626349e-01 | 0.581 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.654609e-01 | 0.576 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.658522e-01 | 0.575 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 2.658522e-01 | 0.575 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.686682e-01 | 0.571 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.686682e-01 | 0.571 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.708260e-01 | 0.567 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.709859e-01 | 0.567 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.709859e-01 | 0.567 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.717074e-01 | 0.566 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.718789e-01 | 0.566 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.718789e-01 | 0.566 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.785046e-01 | 0.555 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.785046e-01 | 0.555 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.785046e-01 | 0.555 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.785046e-01 | 0.555 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 2.785046e-01 | 0.555 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.785046e-01 | 0.555 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.785046e-01 | 0.555 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 2.785046e-01 | 0.555 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.785046e-01 | 0.555 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.785046e-01 | 0.555 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.785046e-01 | 0.555 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.785046e-01 | 0.555 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.785046e-01 | 0.555 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.785046e-01 | 0.555 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.785046e-01 | 0.555 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.800921e-01 | 0.553 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.826711e-01 | 0.549 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 2.826711e-01 | 0.549 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.826711e-01 | 0.549 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.854296e-01 | 0.545 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.854833e-01 | 0.544 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.854833e-01 | 0.544 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.861357e-01 | 0.543 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.875097e-01 | 0.541 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.902683e-01 | 0.537 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.902683e-01 | 0.537 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.902683e-01 | 0.537 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.902716e-01 | 0.537 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.902716e-01 | 0.537 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.902716e-01 | 0.537 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.902716e-01 | 0.537 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.916439e-01 | 0.535 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 2.965831e-01 | 0.528 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.965831e-01 | 0.528 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.965831e-01 | 0.528 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.965831e-01 | 0.528 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.965831e-01 | 0.528 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.965831e-01 | 0.528 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.965831e-01 | 0.528 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.978637e-01 | 0.526 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.995626e-01 | 0.524 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.031639e-01 | 0.518 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.089031e-01 | 0.510 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.091671e-01 | 0.510 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.120571e-01 | 0.506 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 3.120571e-01 | 0.506 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.120571e-01 | 0.506 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.120571e-01 | 0.506 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.120571e-01 | 0.506 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.120571e-01 | 0.506 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.125621e-01 | 0.505 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.144432e-01 | 0.502 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.144432e-01 | 0.502 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.144432e-01 | 0.502 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.160145e-01 | 0.500 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.160145e-01 | 0.500 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.215314e-01 | 0.493 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.215314e-01 | 0.493 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.312082e-01 | 0.480 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.336682e-01 | 0.477 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.336682e-01 | 0.477 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.362386e-01 | 0.473 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.362386e-01 | 0.473 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.387768e-01 | 0.470 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.387768e-01 | 0.470 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.387768e-01 | 0.470 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.387921e-01 | 0.470 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.387921e-01 | 0.470 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.387921e-01 | 0.470 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.388724e-01 | 0.470 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.415146e-01 | 0.467 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.415146e-01 | 0.467 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.415146e-01 | 0.467 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.472368e-01 | 0.459 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.472368e-01 | 0.459 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.496144e-01 | 0.456 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.528987e-01 | 0.452 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.528987e-01 | 0.452 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.528987e-01 | 0.452 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.528987e-01 | 0.452 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.528987e-01 | 0.452 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 3.528987e-01 | 0.452 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.528987e-01 | 0.452 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.548922e-01 | 0.450 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.548922e-01 | 0.450 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.561684e-01 | 0.448 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.614360e-01 | 0.442 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.631689e-01 | 0.440 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.671934e-01 | 0.435 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.708713e-01 | 0.431 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.708713e-01 | 0.431 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 3.708713e-01 | 0.431 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.732750e-01 | 0.428 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.735551e-01 | 0.428 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.735953e-01 | 0.428 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.736230e-01 | 0.428 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.751982e-01 | 0.426 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.751982e-01 | 0.426 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.751982e-01 | 0.426 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.751982e-01 | 0.426 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 3.751982e-01 | 0.426 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.751982e-01 | 0.426 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.751982e-01 | 0.426 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.751982e-01 | 0.426 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.751982e-01 | 0.426 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.761671e-01 | 0.425 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.761671e-01 | 0.425 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.761671e-01 | 0.425 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 3.795560e-01 | 0.421 | 1 | 1 |
| Signaling by ALK | R-HSA-201556 | 3.848795e-01 | 0.415 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.875227e-01 | 0.412 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 3.875227e-01 | 0.412 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.933203e-01 | 0.405 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.974289e-01 | 0.401 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.999736e-01 | 0.398 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.999736e-01 | 0.398 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.999736e-01 | 0.398 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.022323e-01 | 0.396 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.039897e-01 | 0.394 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.039897e-01 | 0.394 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.070739e-01 | 0.390 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.117483e-01 | 0.385 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.131841e-01 | 0.384 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.131841e-01 | 0.384 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.131841e-01 | 0.384 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.131841e-01 | 0.384 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.131841e-01 | 0.384 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.131841e-01 | 0.384 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.131841e-01 | 0.384 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.131841e-01 | 0.384 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.186170e-01 | 0.378 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.186170e-01 | 0.378 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.186170e-01 | 0.378 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.196260e-01 | 0.377 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.196260e-01 | 0.377 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.196260e-01 | 0.377 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.196260e-01 | 0.377 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.196260e-01 | 0.377 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.196260e-01 | 0.377 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.203570e-01 | 0.376 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.260964e-01 | 0.370 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.286863e-01 | 0.368 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.286863e-01 | 0.368 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.286863e-01 | 0.368 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.318078e-01 | 0.365 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.324147e-01 | 0.364 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.373105e-01 | 0.359 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.396747e-01 | 0.357 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.396747e-01 | 0.357 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 4.453120e-01 | 0.351 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.499830e-01 | 0.347 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.499830e-01 | 0.347 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.499830e-01 | 0.347 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.499830e-01 | 0.347 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.499830e-01 | 0.347 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.499830e-01 | 0.347 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.499830e-01 | 0.347 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.499830e-01 | 0.347 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.499830e-01 | 0.347 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.499830e-01 | 0.347 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.499830e-01 | 0.347 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.564405e-01 | 0.341 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.568921e-01 | 0.340 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.568921e-01 | 0.340 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.568921e-01 | 0.340 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.568921e-01 | 0.340 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.568921e-01 | 0.340 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.568921e-01 | 0.340 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.568921e-01 | 0.340 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.568921e-01 | 0.340 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.594926e-01 | 0.338 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.596141e-01 | 0.338 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.605516e-01 | 0.337 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.608846e-01 | 0.336 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.639236e-01 | 0.334 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.713737e-01 | 0.327 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.780321e-01 | 0.321 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.794760e-01 | 0.319 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.794760e-01 | 0.319 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.794760e-01 | 0.319 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 4.794760e-01 | 0.319 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 4.794760e-01 | 0.319 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.794760e-01 | 0.319 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.794760e-01 | 0.319 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.794760e-01 | 0.319 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.794760e-01 | 0.319 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.794760e-01 | 0.319 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 4.794760e-01 | 0.319 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.794760e-01 | 0.319 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.794760e-01 | 0.319 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.794760e-01 | 0.319 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.811909e-01 | 0.318 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.811909e-01 | 0.318 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.828686e-01 | 0.316 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.828686e-01 | 0.316 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.828686e-01 | 0.316 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.828686e-01 | 0.316 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.828686e-01 | 0.316 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.828686e-01 | 0.316 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.844902e-01 | 0.315 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.844902e-01 | 0.315 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.844902e-01 | 0.315 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.854358e-01 | 0.314 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.854358e-01 | 0.314 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.854358e-01 | 0.314 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.854358e-01 | 0.314 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.854358e-01 | 0.314 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.854358e-01 | 0.314 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.854358e-01 | 0.314 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.924742e-01 | 0.308 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.980593e-01 | 0.303 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.007283e-01 | 0.300 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.015555e-01 | 0.300 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.049912e-01 | 0.297 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.058312e-01 | 0.296 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.058312e-01 | 0.296 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.155538e-01 | 0.288 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.163152e-01 | 0.287 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.163152e-01 | 0.287 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.194289e-01 | 0.284 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.194289e-01 | 0.284 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.194289e-01 | 0.284 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.194289e-01 | 0.284 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.194289e-01 | 0.284 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.194289e-01 | 0.284 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.194289e-01 | 0.284 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.194289e-01 | 0.284 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.194289e-01 | 0.284 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.194289e-01 | 0.284 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.225414e-01 | 0.282 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.238425e-01 | 0.281 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.283272e-01 | 0.277 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.283272e-01 | 0.277 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.299174e-01 | 0.276 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.331572e-01 | 0.273 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.331572e-01 | 0.273 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.331572e-01 | 0.273 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.331572e-01 | 0.273 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.331572e-01 | 0.273 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.331572e-01 | 0.273 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.331572e-01 | 0.273 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.331572e-01 | 0.273 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.331572e-01 | 0.273 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.331572e-01 | 0.273 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 5.343094e-01 | 0.272 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.375390e-01 | 0.270 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.375390e-01 | 0.270 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.375390e-01 | 0.270 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.412936e-01 | 0.267 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.412936e-01 | 0.267 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.450749e-01 | 0.264 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.503104e-01 | 0.259 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.503104e-01 | 0.259 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.518863e-01 | 0.258 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.518863e-01 | 0.258 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.518863e-01 | 0.258 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.518863e-01 | 0.258 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.518863e-01 | 0.258 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.518863e-01 | 0.258 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.518863e-01 | 0.258 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.518863e-01 | 0.258 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.520146e-01 | 0.258 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.605973e-01 | 0.251 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.605973e-01 | 0.251 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.628628e-01 | 0.250 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.628628e-01 | 0.250 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.628628e-01 | 0.250 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.649552e-01 | 0.248 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.794841e-01 | 0.237 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.794841e-01 | 0.237 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.813052e-01 | 0.236 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.813052e-01 | 0.236 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.813052e-01 | 0.236 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.813052e-01 | 0.236 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.813052e-01 | 0.236 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.813052e-01 | 0.236 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.813052e-01 | 0.236 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.813052e-01 | 0.236 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.813052e-01 | 0.236 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.813052e-01 | 0.236 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.813052e-01 | 0.236 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.813052e-01 | 0.236 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.813052e-01 | 0.236 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.813052e-01 | 0.236 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.813052e-01 | 0.236 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.827633e-01 | 0.235 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.827633e-01 | 0.235 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.827633e-01 | 0.235 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.827633e-01 | 0.235 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.827633e-01 | 0.235 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.827633e-01 | 0.235 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.838122e-01 | 0.234 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.842890e-01 | 0.233 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.864614e-01 | 0.232 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.873230e-01 | 0.231 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.873230e-01 | 0.231 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.876092e-01 | 0.231 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.903438e-01 | 0.229 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.907977e-01 | 0.229 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.928684e-01 | 0.227 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.965981e-01 | 0.224 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.979287e-01 | 0.223 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.988260e-01 | 0.223 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.108865e-01 | 0.214 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.120406e-01 | 0.213 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.120406e-01 | 0.213 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.120406e-01 | 0.213 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.120406e-01 | 0.213 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 6.120406e-01 | 0.213 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.120406e-01 | 0.213 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.128190e-01 | 0.213 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.128190e-01 | 0.213 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.131050e-01 | 0.212 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.131050e-01 | 0.212 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.159095e-01 | 0.210 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.159095e-01 | 0.210 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.159095e-01 | 0.210 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.159095e-01 | 0.210 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.194871e-01 | 0.208 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.213118e-01 | 0.207 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.244900e-01 | 0.204 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.244900e-01 | 0.204 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.244900e-01 | 0.204 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.244900e-01 | 0.204 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.244900e-01 | 0.204 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.244900e-01 | 0.204 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.244900e-01 | 0.204 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.244900e-01 | 0.204 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.244900e-01 | 0.204 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.244900e-01 | 0.204 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.244900e-01 | 0.204 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.244900e-01 | 0.204 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.324166e-01 | 0.199 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.324166e-01 | 0.199 | 1 | 1 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.324166e-01 | 0.199 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.334082e-01 | 0.198 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.335301e-01 | 0.198 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.335301e-01 | 0.198 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.335301e-01 | 0.198 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.335301e-01 | 0.198 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.335301e-01 | 0.198 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.335301e-01 | 0.198 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.354250e-01 | 0.197 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.397196e-01 | 0.194 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.397196e-01 | 0.194 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.397196e-01 | 0.194 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.397196e-01 | 0.194 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 6.408427e-01 | 0.193 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.504098e-01 | 0.187 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.513627e-01 | 0.186 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.513627e-01 | 0.186 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.532628e-01 | 0.185 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.552395e-01 | 0.184 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.552395e-01 | 0.184 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.632229e-01 | 0.178 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.632229e-01 | 0.178 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.632229e-01 | 0.178 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.632229e-01 | 0.178 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.632229e-01 | 0.178 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.632229e-01 | 0.178 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.632229e-01 | 0.178 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.632229e-01 | 0.178 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.632229e-01 | 0.178 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.632229e-01 | 0.178 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.632229e-01 | 0.178 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.632229e-01 | 0.178 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.632229e-01 | 0.178 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.632229e-01 | 0.178 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.632229e-01 | 0.178 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.658187e-01 | 0.177 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.658187e-01 | 0.177 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.658187e-01 | 0.177 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.658187e-01 | 0.177 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.658187e-01 | 0.177 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.658187e-01 | 0.177 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.669024e-01 | 0.176 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.706931e-01 | 0.173 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.706931e-01 | 0.173 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.760085e-01 | 0.170 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.760085e-01 | 0.170 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.760085e-01 | 0.170 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.760085e-01 | 0.170 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.760085e-01 | 0.170 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.802579e-01 | 0.167 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.807911e-01 | 0.167 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.828771e-01 | 0.166 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.872569e-01 | 0.163 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.872569e-01 | 0.163 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.872569e-01 | 0.163 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.903692e-01 | 0.161 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.903692e-01 | 0.161 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.903692e-01 | 0.161 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.903692e-01 | 0.161 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.903692e-01 | 0.161 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.910903e-01 | 0.160 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.950683e-01 | 0.158 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.957824e-01 | 0.158 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.958375e-01 | 0.157 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.958375e-01 | 0.157 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.958375e-01 | 0.157 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.979626e-01 | 0.156 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.979626e-01 | 0.156 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.979626e-01 | 0.156 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.979626e-01 | 0.156 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.979626e-01 | 0.156 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.979626e-01 | 0.156 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.979626e-01 | 0.156 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.979626e-01 | 0.156 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.979626e-01 | 0.156 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.979626e-01 | 0.156 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.979626e-01 | 0.156 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.979626e-01 | 0.156 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 6.979626e-01 | 0.156 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.979626e-01 | 0.156 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.979626e-01 | 0.156 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.979626e-01 | 0.156 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.979626e-01 | 0.156 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.979626e-01 | 0.156 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.979626e-01 | 0.156 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.979626e-01 | 0.156 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.979626e-01 | 0.156 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.983275e-01 | 0.156 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.983275e-01 | 0.156 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.995467e-01 | 0.155 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.063622e-01 | 0.151 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.134128e-01 | 0.147 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.134128e-01 | 0.147 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.134128e-01 | 0.147 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.134128e-01 | 0.147 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.134128e-01 | 0.147 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.134128e-01 | 0.147 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.147332e-01 | 0.146 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.147332e-01 | 0.146 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.260821e-01 | 0.139 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.284483e-01 | 0.138 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.291207e-01 | 0.137 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.291207e-01 | 0.137 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.291207e-01 | 0.137 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.291207e-01 | 0.137 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.291207e-01 | 0.137 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.291207e-01 | 0.137 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.291207e-01 | 0.137 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.291207e-01 | 0.137 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.291207e-01 | 0.137 | 0 | 0 |
| Expression of NOTCH2NL genes | R-HSA-9911233 | 7.291207e-01 | 0.137 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.291207e-01 | 0.137 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.291207e-01 | 0.137 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.291207e-01 | 0.137 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.291207e-01 | 0.137 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.327072e-01 | 0.135 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.327072e-01 | 0.135 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.349991e-01 | 0.134 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.349991e-01 | 0.134 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.349991e-01 | 0.134 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.349991e-01 | 0.134 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.360464e-01 | 0.133 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.360464e-01 | 0.133 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.367926e-01 | 0.133 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.398536e-01 | 0.131 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.459648e-01 | 0.127 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.478333e-01 | 0.126 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.478333e-01 | 0.126 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.478333e-01 | 0.126 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.478333e-01 | 0.126 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.478333e-01 | 0.126 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.497758e-01 | 0.125 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.497758e-01 | 0.125 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.509712e-01 | 0.124 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.509712e-01 | 0.124 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.509712e-01 | 0.124 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.551835e-01 | 0.122 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.551835e-01 | 0.122 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.551835e-01 | 0.122 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.551835e-01 | 0.122 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.570661e-01 | 0.121 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.570661e-01 | 0.121 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.570661e-01 | 0.121 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.570661e-01 | 0.121 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 7.570661e-01 | 0.121 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.570661e-01 | 0.121 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.570661e-01 | 0.121 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.570661e-01 | 0.121 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.599344e-01 | 0.119 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.651610e-01 | 0.116 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.659586e-01 | 0.116 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.716026e-01 | 0.113 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.729839e-01 | 0.112 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.740255e-01 | 0.111 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.740255e-01 | 0.111 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.740255e-01 | 0.111 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.740255e-01 | 0.111 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.740255e-01 | 0.111 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.788602e-01 | 0.109 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.788602e-01 | 0.109 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.799616e-01 | 0.108 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.812785e-01 | 0.107 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.812785e-01 | 0.107 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.812785e-01 | 0.107 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.812785e-01 | 0.107 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.821301e-01 | 0.107 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.821301e-01 | 0.107 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.821301e-01 | 0.107 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.821301e-01 | 0.107 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.828418e-01 | 0.106 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.837936e-01 | 0.106 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.866780e-01 | 0.104 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.915871e-01 | 0.102 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.915871e-01 | 0.102 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.915871e-01 | 0.102 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.915871e-01 | 0.102 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.928377e-01 | 0.101 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.046094e-01 | 0.094 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.046094e-01 | 0.094 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.046094e-01 | 0.094 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.046094e-01 | 0.094 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.046094e-01 | 0.094 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.046094e-01 | 0.094 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.063165e-01 | 0.093 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.079319e-01 | 0.093 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.079319e-01 | 0.093 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.079319e-01 | 0.093 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.079319e-01 | 0.093 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.079319e-01 | 0.093 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.094328e-01 | 0.092 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.126795e-01 | 0.090 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.147829e-01 | 0.089 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.223231e-01 | 0.085 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.231240e-01 | 0.085 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.231240e-01 | 0.085 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.242219e-01 | 0.084 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.247706e-01 | 0.084 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.247706e-01 | 0.084 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.247706e-01 | 0.084 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.247706e-01 | 0.084 | 0 | 0 |
| Acetylation | R-HSA-156582 | 8.247706e-01 | 0.084 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.247706e-01 | 0.084 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.247706e-01 | 0.084 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.247706e-01 | 0.084 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.247706e-01 | 0.084 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.247706e-01 | 0.084 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.247706e-01 | 0.084 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.247706e-01 | 0.084 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.271561e-01 | 0.082 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.277008e-01 | 0.082 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.344614e-01 | 0.079 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.372272e-01 | 0.077 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.372272e-01 | 0.077 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.372272e-01 | 0.077 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.428525e-01 | 0.074 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.428525e-01 | 0.074 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.428525e-01 | 0.074 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.428525e-01 | 0.074 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.428525e-01 | 0.074 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.428525e-01 | 0.074 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.428525e-01 | 0.074 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.428525e-01 | 0.074 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.458785e-01 | 0.073 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.503043e-01 | 0.070 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.503043e-01 | 0.070 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.503043e-01 | 0.070 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.503043e-01 | 0.070 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.503043e-01 | 0.070 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.503043e-01 | 0.070 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.503043e-01 | 0.070 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.503043e-01 | 0.070 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.503043e-01 | 0.070 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.503043e-01 | 0.070 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.523751e-01 | 0.069 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.523751e-01 | 0.069 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.573435e-01 | 0.067 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.590695e-01 | 0.066 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 8.590695e-01 | 0.066 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.590695e-01 | 0.066 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.590695e-01 | 0.066 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.590695e-01 | 0.066 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.590695e-01 | 0.066 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.590695e-01 | 0.066 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.590695e-01 | 0.066 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.590695e-01 | 0.066 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.590695e-01 | 0.066 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.590695e-01 | 0.066 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.590695e-01 | 0.066 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.608994e-01 | 0.065 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.608994e-01 | 0.065 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.608994e-01 | 0.065 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.608994e-01 | 0.065 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.624170e-01 | 0.064 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.624170e-01 | 0.064 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.624170e-01 | 0.064 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.665598e-01 | 0.062 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.665598e-01 | 0.062 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.666722e-01 | 0.062 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.666722e-01 | 0.062 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.690070e-01 | 0.061 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.736138e-01 | 0.059 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.736138e-01 | 0.059 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.736138e-01 | 0.059 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 8.736138e-01 | 0.059 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.736138e-01 | 0.059 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.736138e-01 | 0.059 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.736138e-01 | 0.059 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.736138e-01 | 0.059 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.736138e-01 | 0.059 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.736138e-01 | 0.059 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.736250e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.736250e-01 | 0.059 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.761108e-01 | 0.057 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.761108e-01 | 0.057 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.779206e-01 | 0.057 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.824722e-01 | 0.054 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.826387e-01 | 0.054 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.832732e-01 | 0.054 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.839859e-01 | 0.054 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.839859e-01 | 0.054 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.839859e-01 | 0.054 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.843615e-01 | 0.053 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.849516e-01 | 0.053 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.849516e-01 | 0.053 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.849516e-01 | 0.053 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.849516e-01 | 0.053 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.866579e-01 | 0.052 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.866579e-01 | 0.052 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.866579e-01 | 0.052 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.866579e-01 | 0.052 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.866579e-01 | 0.052 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.866579e-01 | 0.052 | 0 | 0 |
| Mitochondrial Uncoupling | R-HSA-166187 | 8.866579e-01 | 0.052 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.866579e-01 | 0.052 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.866579e-01 | 0.052 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.867642e-01 | 0.052 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.905069e-01 | 0.050 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.932246e-01 | 0.049 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.935552e-01 | 0.049 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.935552e-01 | 0.049 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.944076e-01 | 0.048 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.948532e-01 | 0.048 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.983564e-01 | 0.047 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.983564e-01 | 0.047 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.983564e-01 | 0.047 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.983564e-01 | 0.047 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.023858e-01 | 0.045 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.023858e-01 | 0.045 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.023858e-01 | 0.045 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.023858e-01 | 0.045 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.049209e-01 | 0.043 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.088481e-01 | 0.042 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.088481e-01 | 0.042 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.088481e-01 | 0.042 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.088481e-01 | 0.042 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.088481e-01 | 0.042 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.088481e-01 | 0.042 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.103882e-01 | 0.041 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.105282e-01 | 0.041 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.149292e-01 | 0.039 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.182574e-01 | 0.037 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.182574e-01 | 0.037 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.182574e-01 | 0.037 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.182574e-01 | 0.037 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.182574e-01 | 0.037 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.192131e-01 | 0.037 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.192131e-01 | 0.037 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.192131e-01 | 0.037 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.212191e-01 | 0.036 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.212191e-01 | 0.036 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.255088e-01 | 0.034 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.262511e-01 | 0.033 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.266959e-01 | 0.033 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.266959e-01 | 0.033 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.266959e-01 | 0.033 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.266959e-01 | 0.033 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.266959e-01 | 0.033 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.266959e-01 | 0.033 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.266959e-01 | 0.033 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.266959e-01 | 0.033 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.268468e-01 | 0.033 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.275874e-01 | 0.033 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.298544e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.312933e-01 | 0.031 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.325292e-01 | 0.030 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.325292e-01 | 0.030 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.325395e-01 | 0.030 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.340526e-01 | 0.030 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.342637e-01 | 0.030 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.342637e-01 | 0.030 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.342637e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.342637e-01 | 0.030 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.342637e-01 | 0.030 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.342637e-01 | 0.030 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.345904e-01 | 0.029 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.371370e-01 | 0.028 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.371370e-01 | 0.028 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.371370e-01 | 0.028 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.376193e-01 | 0.028 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.376193e-01 | 0.028 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.388343e-01 | 0.027 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.388343e-01 | 0.027 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.410506e-01 | 0.026 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.410506e-01 | 0.026 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.410506e-01 | 0.026 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.410506e-01 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.410506e-01 | 0.026 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.412453e-01 | 0.026 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.423434e-01 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.425068e-01 | 0.026 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.454120e-01 | 0.024 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.456281e-01 | 0.024 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.471372e-01 | 0.024 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.471372e-01 | 0.024 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.499880e-01 | 0.022 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.508111e-01 | 0.022 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.510345e-01 | 0.022 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.519650e-01 | 0.021 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.519650e-01 | 0.021 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.525956e-01 | 0.021 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 9.525956e-01 | 0.021 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.525956e-01 | 0.021 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.525956e-01 | 0.021 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.525956e-01 | 0.021 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.525956e-01 | 0.021 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.525956e-01 | 0.021 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.525956e-01 | 0.021 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.525956e-01 | 0.021 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.532540e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.561175e-01 | 0.019 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.563386e-01 | 0.019 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.569545e-01 | 0.019 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.574907e-01 | 0.019 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.574907e-01 | 0.019 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.613616e-01 | 0.017 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.613616e-01 | 0.017 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.618806e-01 | 0.017 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.622878e-01 | 0.017 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.639664e-01 | 0.016 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.658174e-01 | 0.015 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.658174e-01 | 0.015 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.658174e-01 | 0.015 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.666107e-01 | 0.015 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.693478e-01 | 0.014 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.693478e-01 | 0.014 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.693478e-01 | 0.014 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.693478e-01 | 0.014 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.693502e-01 | 0.014 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.693502e-01 | 0.014 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.721481e-01 | 0.012 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.721481e-01 | 0.012 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.722159e-01 | 0.012 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.722159e-01 | 0.012 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.725138e-01 | 0.012 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.725138e-01 | 0.012 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.747788e-01 | 0.011 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.747788e-01 | 0.011 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.749288e-01 | 0.011 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.753529e-01 | 0.011 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.753529e-01 | 0.011 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.767868e-01 | 0.010 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.778990e-01 | 0.010 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.778990e-01 | 0.010 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.778990e-01 | 0.010 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.778990e-01 | 0.010 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.801821e-01 | 0.009 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.809773e-01 | 0.008 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.816467e-01 | 0.008 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.816467e-01 | 0.008 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.822295e-01 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.826308e-01 | 0.008 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.836353e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.837307e-01 | 0.007 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.844134e-01 | 0.007 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.845017e-01 | 0.007 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.855234e-01 | 0.006 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.857119e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.857119e-01 | 0.006 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.863480e-01 | 0.006 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.868240e-01 | 0.006 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.869283e-01 | 0.006 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.871883e-01 | 0.006 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.871883e-01 | 0.006 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.885122e-01 | 0.005 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.889875e-01 | 0.005 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.896994e-01 | 0.004 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.902071e-01 | 0.004 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.904218e-01 | 0.004 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.907639e-01 | 0.004 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.907639e-01 | 0.004 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.909193e-01 | 0.004 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.915016e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.917185e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.917185e-01 | 0.004 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.917976e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.933421e-01 | 0.003 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.934569e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.940303e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.940303e-01 | 0.003 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.940303e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.947285e-01 | 0.002 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.947497e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.949191e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.949191e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.953857e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.953982e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.955296e-01 | 0.002 | 1 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.956970e-01 | 0.002 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.961419e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.961963e-01 | 0.002 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.964741e-01 | 0.002 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.965409e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.965409e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.968986e-01 | 0.001 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.970507e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.979959e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.980931e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.982032e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.982544e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.983891e-01 | 0.001 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.985484e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.985675e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.987596e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.987789e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.990059e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.990669e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.992479e-01 | 0.000 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.992501e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.992901e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.996414e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.996805e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997195e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997195e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.997691e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.997698e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.997979e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.997979e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998189e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998231e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.998341e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998376e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.998594e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.998695e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998745e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999158e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999245e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999245e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999393e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999466e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999747e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999874e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999890e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999895e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999904e-01 | 0.000 | 1 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999906e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999915e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999932e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999959e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999961e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999982e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999992e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999994e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999994e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999996e-01 | 0.000 | 1 | 0 |
| Complement cascade | R-HSA-166658 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999997e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |